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Toxoplasma gondii is a protozoan parasite that can infect almost all warm-blooded 
animals, including birds and humans. The definitive host is the cat which excretes 
the highly infectious and environmental resistant oocyst stage. Unlike other     
coccidian parasites, such as Neospora caninum and Eimeria, T. gondii does not 
wholly rely on its sexual stage in felids to successfully be transmitted to other 
hosts and host species. Equally important for the spread of T. gondii is the trans-
mission of T. gondii by ingestion of contaminated food (prey) between host spe-
cies. In fact, sexual recombination is a relatively rare event observed in T. gondii. 
This is one of the reasons why a clonal population structure of T. gondii is ob-
served. In Europe and North America the majority of genotypes (types) of T. 
gondii are members of only three canonical clonal types, designated type I, type II 
and type III. In South America and Asia, T. gondii is shown to have an increased 
genetic diversity with a high prevalence of non-canonical or atypical genotypes. 
However, even within those non-canonical or atypical genotypes, a clonal popula-
tion structure can be observed. More importantly, mouse virulence of types I, II 
and III differ markedly. While infection with T. gondii type I is always lethal in 
mice (Lethal Dose100 = 1 parasite), infections with 104–106 parasites of type II or 
type III are needed to have the same effect in mice (LD50 = 103–105 parasites). 
This study shows that the majority of cats in Germany excrete T. gondii oocysts of 
type II. We have not observed any type I T. gondii, but show that type III and, im-
portantly, mixed type infection as well as non-canonical T. gondii are present in 
Germany. For the first time we demonstrate that a sexual cross between T. gondii 
type II and type III in a single, naturally infected cat occurred in Germany result-
ing in excretion of many genetically different non-canonical T. gondii. Most of the 
identified non-canonical T. gondii show a high virulence in mice. The RFLP-
typing analysis of a limited number of T. gondii-DNA isolated from human sam-
ples revealed only alleles of T. gondii type II. I show that genetic recombination of 
different T. gondii types in Germany can lead to a higher genetic diversity and 





Toxoplasma gondii weist eine weltweite Verbreitung auf und kann fast alle Wir-
beltiere, vor allem Vögel und Menschen infizieren. Felide sind Endwirte von T. 
gondii, welche das infektiöse und umweltresistente Oozysten-Stadium ausschei-
den können. Im Gegensatz zu anderen parasitären Erregern, wie zum Beispiel 
Neospora caninum und Eimeria, kann T. gondii auch ohne sexuelle Vermehrung 
unterschiedlichste Zwischenwirte und Zwischenwirtspezies infizieren. Obwohl 
eine sexuelle Phase ein Teil des Lebenszyklus ist, werden rekombinierte Genoty-
pen nur sehr selten beobachtet. Dies ist ein Grund dafür, warum T. gondii eine 
klonale Populationsstruktur erkennen lässt. Während in Nordamerika und Europa 
drei klonale Genotypen (Typ I, II und III) dominieren, werden in Südamerika und 
Asien, neben den drei bekannten auch atypische und andere Genotypen beobach-
tet. Aber auch innerhalb der atypischen Genotypen lässt sich eine klonale Popula-
tionsstruktur erkennen. Die klonalen Linien I, II und III weisen Unterschiede in 
ihrer Virulenz für Mäuse auf. Typ-I-Stämme sind hochvirulent. Die Infektion mit 
nur einem Organismus führt bereits zum Tod. Klonale Typ-II- und Typ-III-
Stämme sind avirulent für Mäuse. Nur Infektionen mit mehr als 103 Organismen 
führen zum Tod. In dieser Studie zeige ich, dass die Mehrzahl isolierter T. gondii-
Oozysten dem Typ II zuzuordnen ist. Es wurde keine Typ-I-, dafür aber eine Typ-
III-Infektion und vereinzelte Hinweise auf Mischinfektionen und nicht-kanonische 
T. gondii Genotypen beobachtet. Erstmalig kann gezeigt werden, dass aus einer 
Rekombination zwischen den klonalen Typen II und III genetisch unterschiedliche 
T. gondii in einer natürlich infizierten Katze entstanden sind. Die identifizierten 
nicht-kanonischen T. gondii Klone weisen unterschiedliche, meist hohe Virulenz 
im Mausmodell auf. Eine geringe Anzahl von T. gondii-DNA Proben von huma-
nen Toxoplasmose-Fällen deutet auf eine Infektion mit T. gondii des Typs II hin. 
Ich zeige mit dieser Studie, dass sexuelle Rekombination von T. gondii in 
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1.1 General information 
Toxoplasma gondii is one of the most prevalent and most successful para-
sites worldwide. It is thought to be able to infect all warm-blooded animals found 
in most regions of the world. There is evidence of its existence on almost all con-
tinents, Europe, North and South America, Asia, Africa, the Arctic and Australia, 
except for Antarctica. It can cause a wide spectrum of disease manifestations in its 
host animals. This ranges from no or malign symptoms to death, such as in sea 
mammals. It is of major concern in many species, especially in livestock animals 
as well as humans, with a congenital infection of T. gondii. This can lead to dam-
age in the developing foetus or spontaneous abortion. 
Initially, T. gondii was found in Ctenodactylus gundi, a desert rodent in Tu-
nisia that was used for Leishmania research at the time, and therefore wrongly 
believed to be Leishmania. However, morphological examination and comparison 
revealed the discovery of a new parasite by [Nicolle and Manceaux, 1908]. At the 
same time, [Splendore, 1908] also isolated the same organism from rabbits in 
Brazil. Years later, T. gondii was isolated from different animals but also humans 
[Sabin, 1939; Wolf et al., 1939]. 
1.2 Lifecycle of T. gondii 
One of the major advantages of this parasite is the ability to infect and to 
persist in almost all warm-blooded animals worldwide. Its lifecycle was first de-
scribed in 1965 [Hutchison, 1965] but was not fully elucidated until 1970 [Frenkel 
et al., 1970; Hutchison et al., 1970; Hutchison et al., 1971]. An overview of the 
lifecycle is shown in Figure 1. 
Toxoplasma life stages can be divided into four major groups: oocysts, 






Unsporulated oocysts are excreted by felids, the definitive hosts of T. gondii, 
within 3-5 days after feeding them tissue cysts [Dubey et al., 1970a]. Oocysts are 
subspherical to ellipsoidal in shape and measure between 10-12 µm [Dubey, 
1998a]. Within 2-7 days they sporulate and only then they are infective for ani-
mals and humans. During sporulation two sporocysts are formed inside the oo-
cysts wall, each containing 4 sporozoites. Oocysts are highly environmentally 
resistant. Desiccation can kill oocysts. While room temperature promotes sporula-
tion, temperatures below 4°C may slow the sporulation process but are not always 
sufficient to prevent sporulation [Dubey et al., 1970b; Frenkel et al., 1970; 
Lindsay et al., 2002]. The oocyst stage can also survive UV-treatment and remains 
infective in water for up to 54 months at 4°C and in soil for 18 months at various 
temperatures [Dubey, 1998a; Dumetre and Darde, 2003; Frenkel et al., 1975]. 
Therefore, once contaminated with oocysts, water, soil and vegetation present a 
major source of T. gondii infection to animals and humans. Indeed, major out-
breaks of toxoplasmosis in Canada and Brazil could be traced back to contaminat-
ed water sources [Bowie et al., 1997; de Moura et al., 2006; Stagno et al., 1980]. 
Upon ingestion of oocysts by an intermediate host, the oocyst wall is digested in 
the small intestine of the intermediate host releasing the sporocysts and sporozo-
ites. Sporozoites penetrate into intestinal cells,  transform into tachyzoites which 
start to multiply asexually  in the lamina propria from where they may spread to 
other tissues to transform later on into bradyzoites which finally form tissue cysts 












Tachyzoites are crescent-shaped and about 6 µm in length. They enter the 
host cell by actively penetrating the cell membrane. Thereafter, the tachyzoite is 
surrounded by a parasitophorous membrane (PVM) which consists of both, host- 
and parasite-derived proteins [Mordue et al., 1999]. Tachyzoites multiply intracel-
lularly by endodyogeny until their growth can no longer be sustained by the host 
cell. The infected cell then ruptures releasing the tachyzoites. The released para-
site stages may then continue to infect neighbouring uninfected cells or can spon-
taneously convert into the slowly replicating bradyzoite stage within infected 
cells. The rate of growth was discovered to be strain- and host cell type-dependent 
[Appleford and Smith, 1997]. Mouse virulent strains of T. gondii were shown to 
grow faster in-vitro than avirulent strains. Although T. gondii isolates have been 
genetically classified into types I, II and III, no structural differences among them 
were apparent [Howe and Sibley, 1995]. Importantly, tachyzoites can be passed 
from maternal blood to the foetal tissue causing congenital T. gondii infections. 
1.2.3 Bradyzoites 
Bradyzoites, which form tissue cysts, can be found as early as three days 
post inoculation (d.p.i) in mice [Dubey and Frenkel, 1976]. The process of stage 
conversion from fast-dividing tachyzoite to slow-dividing bradyzoites seems to be 
a spontaneous process occurring when the replication rate of tachyzoites slows 
down. Consistent with this observation, rapidly dividing T. gondii strains, such as 
RH (type I), form bradyzoites less readily [Bohne et al., 1994; Weiss and Kim, 
2000] than other strains. Stage conversion can be induced in-vitro by temperature 
stress and pH-stress [Soete et al., 1994; Weiss et al., 1995]. Bradyzoites can also 
form when a host ingests oocysts, to a small extent tachyzoites or contaminated 
meat with tissue cysts. It is believed that tissue cysts can periodically rupture thus 
releasing parasites that re-invade host cells and establish new tissue cysts [Reiter-




1.2.4 Sexual stages  
Sexual stages can only develop in felids, the definitive host of T. gondii. Fe-
lids can get infected with T. gondii by ingestion of sporulated oocysts or by ingest-
ing tissues of infected intermediate hosts, e.g. rodents or birds. In both cases, the 
cell wall surrounding bradyzoites, oocysts or the sporocyst will be digested by 
enzymes and the acidic environment of the stomach and enzymes of the intestine, 
to release bradyzoites or sporozoites. These stages undergo several rounds of 
asexual propagation in epithelial enterocytes followed by the formation of sexual 
stages (gametocytosis). A few microgametocytes (males) containing 20-30 micro-
gametes, and large numbers of macrogametocytes (females) are formed. Mature 
macrogametes contain all nutrients required for oocyst formation [Ferguson et al., 
2005]. During sexual propagation, microgametes will invade a single macrogam-
ete thus fertilising it. This process leads to the formation of a diploid zygote that 
will later develop into the oocyst stage. Interestingly, only macrogametogony is 
associated with the synthesis of wall-forming bodies which are required to form 
the oocyst wall [Ferguson, 2002].  
When oocysts are released with feline faeces, they undergo meiosis in the 
environment generating four haploid sporozoites. The prepatent period for oocyst 
shedding in cats is 3–10 d.p.i. after bradyzoite take-up and 18 days or more after 
ingesting oocysts. The prepatent period is reported to be strain-independent 
[Dubey, 2005]. Millions of oocysts can be shed over a period of 14 days by a sin-
gle cat. After sporulation of oocysts in the environment, for example in water, on 
vegetables, food stuff, cat litter, in soil etc., they may be taken up by a wide range 
of intermediate hosts, such as wild and livestock animals, birds or humans. In the 
intermediate host, tachyzoites are formed first, followed by the formation of tissue 
cysts. Tissue cysts are mainly found in the central nervous system (CNS), the eye 
and striated as well as unstriated muscular tissue. However, bradyzoites were also 
shown to be present in visceral organs such as the lungs, liver and kidneys 




diate host. They may persist life-long. Importantly, tissue cysts are also infectious 
for other host species [Dubey, 1998d]. 
 
 
Figure 1: Life cycle of T. gondii.  
Orange arrow: transmission by oocysts, pink arrow: transmission by tachyzoites and/or bradyzo-
ites, curved pink arrow: transmission between species in the wild (prey-predator relationship), 
curved blue arrow: vertical transmission (mother to offspring). 
 
What distinguishes T. gondii from other cyst-forming coccidian is the fact 
that horizontal transmission is not restricted to oocysts, i.e. from definitive to in-
termediate hosts, but also via horizontal transmission by tissue cysts, i.e. between 
intermediate hosts. Another route of infection was shown to be initiated by 
tachyzoites which can be passed vertically from the mother to the offspring. This 




ate host species such as mice [Aramini et al., 1998], rats [Dubey, 1997], sheep 
[Innes, 2009] but also humans [Dunn et al., 1999; Minkoff et al., 1997]. All three 
life-stages (oocysts, tachyzoites, and bradyzoites) are infectious to their host spe-
cies. In the context of parasite survival, it follows that T. gondii may be transmit-
ted from definitive to intermediate hosts, from intermediate to definitive host as 
well as between definitive and between intermediate hosts. In settings where do-
mestic felids are absent, wild felids such as jaguars, lynx or bobcats can serve as 
definitive hosts [Demar et al., 2008; Garcia-Bocanegra et al., 2010; Millan et al., 
2009a; Mucker et al., 2006]. Furthermore, even in the absence of a definitive host, 
T. gondii may persist in the environment by cycling only between intermediate 
host species. Due to this efficient life cycle that includes not only domestic but 
also wild animals, it has been suggested that the T. gondii life cycle may consist of 
two elements, the domestic and the sylvatic (wild) cycle. Although the two cycles 
may exist separately, for example in case of geographic boundaries, exchange will 
be possible at the edge where spill-over may occur [Grigg and Sundar, 2009]. At 
these edges, may it be boundaries of the rainforest and anthropised coastal regions 
of Guiana or the boundary between forest and sub-urban regions in Germany, 
transmission between the sylvatic and the domestic cycle is highly likely [Mercier 
et al., 2011]. 
1.3 T. gondii prevalence in cats and humans in Germany and Europe 
Due to its wide host-range and efficient life cycle, T. gondii is highly preva-
lent in animals and humans worldwide. T. gondii oocyst shedding in cats is diffi-
cult to assess due to the short patent period. Therefore, only few studies were un-
dertaken to analyse oocyst shedding. Most studies consisted of microscopic faecal 
examinations and in some cases these findings were confirmed by a T. gondii-
specific PCR. This fact is important since T. gondii cannot be readily distin-
guished from related oocysts forming protozoan parasites, such as Hammondia. 
Despite the development of molecular methods enabling the distinction of oocysts 




Sreekumar et al., 2005]. Therefore, reports on oocysts need to be studied more 
closely. Comparison of such publications is difficult since different approaches of 
sampling and different methods of detection were applied. Some studies used all 
the faecal matter available [Schares et al., 2008b] while others examined only a 
standardised amount [Miro et al., 2004]. 
Table 1 gives an overview of feline faecal samples of domestic cats exam-
ined for the presence of T. gondii oocysts in Germany and Europe. Seroprevalence 
data suggest that the prevalence of domestic cats infected with T. gondii ranges 
between 26.00 and 65.00% (Table 2). However, the seroprevalence in wild cats 
(Felis sylvestris) was found to be higher with 50–100% (Table 3). [Miro et al., 
2004] reported that T. gondii seroprevalence in stray cats was statistically signifi-
cantly higher than in domestic or farm cats. Several studies also reported a statis-
tically significant correlation between the presence of high antibody titres and 
higher seroprevalences in older cats (older than one year) compared to low anti-
body titres and low seroprevalences in younger cats [De Craeye et al., 2008; Miro 
et al., 2004]. Therefore, primary infection with T. gondii will often occur in cats 
aged one year or younger and re-infection with T. gondii may therefore more fre-












Table 1: Coprological examinations of domestic cats for the presence of T. gondii oocysts in Ger-
many and Europe.   
AUT: Austria; CHE: Switzerland; CZE: Czech Republic; ESP: Spain; FRA: France  
M: microscopic examination; B: bioassay in mice 
Country No. of 
samples 
analysed 




GER 24106 M, PCR 26 (0.11) [Schares et al., 2008b] 
GER 3167 M 142 (4.50) [Barutzki and Schaper, 
2003] 
GER 8560 M 66 (0.8) [Barutzki and Schaper, 
2011] 
AUT 1368 M 27 (2.00) [Edelhofer and Aspöck, 
1996] 
CHE 252 M, PCR 1 (0.40) [Berger-Schoch et al., 
2011b] 
CZE 390 M, B, PCR 0 (0.00) [Svobodova et al., 1998] 
ESP 382 M 0 (0.00) [Miro et al., 2004] 
ESP 592 M 0 (0.00) [Montoya et al., 2008]) 












Table 2: Serological examinations of domestic cats for T. gondii antibodies in Germany and Eu-
rope.  








GER 306 ELISA 138 (45.09) [Tenter et al., 1994] 
GER 300 ELISA 197 (65.60) [Hecking-Veltman et al., 
2001] 
AUT 456 IFAT 220 (48.24) [Edelhofer and Aspöck, 1996] 
BEL 567 IFAT 141 (24.90) [De Craeye et al., 2008] 
CZE 286 IFAT 126 (44.10) [Dubey, 2010] 
ESP 585 IFAT 189 (32.30) [Miro et al., 2004] 
ESP 592 IFAT 103 (17.00) [Montoya et al., 2008] 
FRA 52 MAT 33 (63.45) [Afonso et al., 2006] 















Table 3: Serological examinations of wild or stray cats for T. gondii antibodies in Europe (Spain).  
ESP: Spain; W: wild cat (Felis silvestris); L: lynx (Lynx pardinus); S: stray cat 
Country Species No.  
samples 
analysed 




ESP S 317 IFAT 117 (36.90) [Miro et al., 2004] 
ESP W 12 IFAT 6 (50.00) [Sobrino et al., 2007] 
ESP L 27 IFAT 22 (81.50) [Sobrino et al., 2007] 
ESP L 26 IFAT 21 (80.70) [Millan et al., 2009b] 
ESP W 59 IFAT 50 (84.70) [Millan et al., 2009a] 
Some studies show that experimentally infected cats may be immune to re-
shedding of oocysts upon re-infection with T. gondii [Dubey, 1995; Frenkel and 
Smith, 1982; Lappin et al., 1996]. However, [Dubey, 1996] showed that such im-
munity will decrease with age and that shedding of oocysts can occur after re-
infection with T. gondii six years after the primary infection. 
In cats, T. gondii infection rarely results in fatal or pronounced disease 
symptoms. The main symptoms of toxoplasmosis in cats after natural or experi-
mental infection were reported to include interstitial pneumonia, hepatitis, spleni-
tis, lymphoadenomegaly, and ophthalmitis [Dubey, 2005]. In Europe, only a few 
cases of symptomatic toxoplasmosis in cats were reported from Denmark, Italy 
and Switzerland [Anfray et al., 2005; Henriksen et al., 1994; Spycher et al., 
2011]. 
 
Contamination of food and water with oocysts is one of the main sources for 
human T. gondii infection. Warnings to pregnant women are issued in Germany 
and the EU to highlight this fact [Anonymous, 2007]. However, ingestion of raw 
or undercooked meat containing tissue cysts may also lead to infection with T. 
gondii [Dabritz and Conrad, 2010; Dubey and Jones, 2008; Dubey, 2010]. It has 




fusion [Tenter et al., 2000]. Some of the toxoplasmosis outbreaks in Brazil and 
Canada could be traced back to contaminated water reservoirs [Bowie et al., 1997; 
de Moura et al., 2006]. A multicentre study including Belgium, Denmark, Italy, 
Norway and Switzerland identified ingestion of raw or undercooked meat such as 
lamb and beef, but also contaminated soil as main sources of T. gondii infections 
[Cook et al., 2000]. In Norway, cured meat and poor kitchen hygiene were further 
significant risk factors for infection [Kapperud et al., 1996]. Since  the first suc-
cessful isolation of T. gondii from humans and animals [Sabin and Olitsky, 1937] 
and the introduction of the dye test [Sabin and Feldman, 1948], T. gondii was rec-
ognised as a parasitic disease of animals and humans occurring worldwide. It is 
estimated that up to one third of the human population is infected with T. gondii. 
However, seroprevalences vary greatly between continents, geographical regions 
and ethnic groups [Tenter et al., 2000]. Seroprevalence studies from Spain 
showed that 41.00% of migrant women had IgG anti-T. gondii antibodies [Ramos 
et al., 2011], whereas only 12.00% of Spaniards tested positive for T. gondii. 
In 2005, 1,519 (0.84 cases per 100,000 inhabitants) toxoplasmosis cases 
were reported to the European Centre for Disease Prevention and Control (ECDC) 
by 14 European countries. Of those countries, Lithuania and Slovakia reported the 
highest incidences with 6.86 and 4.84 per 100,000. Unfortunately, there is high 
variation between member countries in the criteria for reporting cases of clinical 
toxoplasmosis. Whereas in Norway only encephalitis cases need to be reported, 
Denmark also reports congenital cases from neonatal screening. Furthermore, only 
nine of the 25 EU member states submitted data to the ECDC in 2005. Together 
with data from the USA, a decrease in the T. gondii seroprevalence has been ob-
served since 1999 [European Centre of Disease and Control, 2007; Jones et al., 
2009]. Like the seroprevalence in cats, T. gondii seroprevalence in humans is also 
shown to increase with age [Jones et al., 2001]. There is very little information on 
the epidemiology of human toxoplasmosis in Germany, but a lot more research is 




Generally, different forms of human toxoplasmosis can be observed. Con-
genital toxoplasmosis (CT) occurs when a woman becomes infected with T. 
gondii during pregnancy. This can result in a transplacental transmission of the 
parasite to the foetus leading to a wide range of clinical manifestations such as 
foetal death, hydrocephalus, intercerebral calcifications, mental retardations, or 
retinochoroiditis. However, infection can also be clinically unapparent. Some 
symptoms may only appear many years post-infection [Remington et al., 2006]. 
Only recently, it was recognised that transmission of T. gondii to the foetus can 
not only occur during a primary infection during gestation but also due to a persis-
tent parasitaemia from an infection contracted prior to conception but continuing 
well into the pregnancy [Lindsay and Dubey, 2011]. Furthermore, in HIV-infected 
or otherwise immunosuppressed mothers, re-activation may lead to vertical 
transmission of T. gondii [Azevedo et al., 2010; Remington et al., 2006]. After it 
had been discovered that different avirulent and virulent strains of T. gondii exist 
[Saeij et al., 2006; Sibley and Boothroyd, 1992b], a further way of vertical trans-
mission has been postulated to occur when an infection with a certain strain of T. 
gondii is followed by a secondary infection with a differing T. gondii strain 
[Elbez-Rubinstein et al., 2009]. Extensive research was undertaken to assess the 
seroprevalence and risk of infection with T. gondii in pregnant women and women 
of child-bearing age; an overview of the results is shown in Table 4. It is estimat-
ed that three foetal losses per year are incurred by infection with T. gondii in the 
Netherlands [Hofhuis et al., 2011; Kortbeek et al., 2009]. However, the overall 
seroprevalence of T. gondii in pregnant women can be quite high. Depending on 
the country, seroprevalences can reach 50–77% as observed in Serbia and France 
[Baril et al., 1999; Bobic et al., 1998], respectively, or may be as low as 3% in 





Table 4: Seroprevalence of T. gondii in pregnant women and women of 
childbearing age in Germany and Europe.  
AUT: Austria; GER: Germany; DNK: Denmark; ESP: Spain; FRA: France; FIN: 
Finland; GRC: Greece; KAZ: Kazakhstan; NLD: Netherlands; NOR: Norway; 
SCG: Serbia; SWE: Sweden 
Country Sample size (n) Prevalence (%) Reference 
GER 2,104 54.00 [Roos et al., 1993] 
GER 5,670 39.00 [Beringer, 1992] 
GER 465 34–61.00 [Gross, 2004] 
AUT 167,041 43.00 [Aspöck and Pollak, 1992] 
DNK 89,875 25.30 [Lebech et al., 1999] 
ESP 1,488 12.00 [Ramos et al., 2011] 
ESP 1,627 41.50 [Ramos et al., 2011] 
FRA 13,459 54.30 [Baril et al., 1999] 
FIN 16,733 20.30 [Lappalainen et al., 1995] 
GRC 9,285   3.10 [Messaritakis et al., 2008] 
GRC 1,157 40.00 [Diza et al., 2005] 
KAZ 3,126 16.00 [Torgerson et al., 2009] 
Kosovo 334 29.40 [Dentico et al., 2011] 
NLD 7,521 40.50 [Kortbeek et al., 2004] 
NOR 35,940 10.90 [Jenum et al., 1998] 
SCG 1,197 77.00 [Bobic et al., 1998] 
SWE 35,000 10.10 [Evengard et al., 2001] 
However, one has to be careful with the interpretation of the results from 
Greece since only the inhabitants of the islands of Crete and Cyprus were exam-
ined and the low seroprevalence was and attributed to an increased consumption 
of frozen food stuff. A more comprehensive study examined 603 confirmed cases 
of T. gondii infections during pregnancy in France. The transmission of T. gondii 
was 26.70% (161/603). In eight cases, vertical transmission resulted in either still 
birth (3) or abortion (5) of the foetus. The remaining 153 births were followed up 




included retinochoroiditis (33), intracerebral calcification (14) or a combination of 
the two clinical symptoms (4) [Dunn et al., 1999]. 
Overall, the T. gondii prevalence is estimated as 1–10 births per 10,000 live 
births [Cook et al., 2000; Evengard et al., 2001]. A study of an acute toxoplasmo-
sis outbreak in Canada showed that the prevalence of T. gondii was 0.90% in 
pregnant women [Burnett et al., 1998]. As for cats, a correlation of age and sero-
prevalence with respect to T. gondii was recognized in humans. Data from Ka-
zakhstan, the Netherlands and Italy confirmed that with increasing age, the risk of 
acquiring T. gondii increased as  vertical transmission did during pregnancy by 
the parasite [Buffolano et al., 1996; Kortbeek et al., 2004; Torgerson et al., 2009]. 
In Poland, 17,653 filter paper samples from live-born neonates were successively 
screened for T. gondii and 19 new-borns (0.11%) were seropositive [Paul et al., 
2001]. In Europe, different treatment regimes are available when congenital toxo-
plasmosis is detected, consisting of the application of spiramycin, pyrimethamine-
sulphonamide, sulfadoxine and pyrimethamine (Fansidar) depending on the tri-
mester of pregnancy [Christoph et al., 2004]. While an outbreak of toxoplasmosis 
in Canada was relatively benign, another one in French Guiana resulted in one 
death and two cases of lethal congenital toxoplasmosis. It was postulated that at 
least 5 of 11 clinical cases observed during this outbreak in French Guiana were 
caused by the same T. gondii strain. However, the isolated T. gondii strain was 
different from strains observed in Europe or the USA [Demar et al., 2007]. 
Ocular toxoplasmosis (OT) can occur after postnatal infection or as a conse-
quence of a congenital infection. Most epidemiological research concludes that 
postnatal infection is the main cause of ocular toxoplasmosis rather than congeni-
tally acquired infection [Gilbert and Stanford, 2000; Holland, 1999, 2000]. T. 
gondii tachyzoites can reach the eye via the blood stream and are arrested in the 
capillary bed of the retina [Roberts and McLeod, 1999]. Within the retina, the 
parasite multiplies causing cell lysis and lesions. Reactivation may also be fol-




Since ocular diseases were also identified in foetuses, ocular toxoplasmosis may 
also be caused in-utero. Although most symptoms are the result of damage by the 
parasite, a pronounced Th1 immune response, especially high concentrations of 
IL-6, TNF-α and IFN-γ were discovered in patients with retinochoroiditis 
[Montoya and Liesenfeld, 2004; Pleyer et al., 2009; Torun et al., 2002]. Clinical 
symptoms include decrease of visual acuity, pain in the eye and photophobia. Ret-
inal lesions may form and thus reduce vision. The extent of damage will depend 
on the location and size of the lesion, as well as the extent of retinal inflammation 
as a response to the parasite [Atmaca et al., 2004; Bosch-Driessen et al., 2002a; 
Bosch-Driessen et al., 2000; Bosch-Driessen et al., 2002b; Munoz et al., 2011]. In 
a study of 14 patients with acquired OT, in 54.00% of the patients reactivation 
occurred within two years [Bosch-Driessen and Rothova, 1999; Bosch-Driessen et 
al., 2002b]. The best described cases were the result of an acute toxoplasmosis 
outbreak in Canada. A total of 100 patients with acquired and 12 patients with 
congenital toxoplasmosis were identified. Twenty patients showed evidence of 
retinal infection whereas no alterations were found in the remaining patients. No 
gender differences were observed and all age groups (15–83 years) were affected. 
Most cases presented unilateral damage to the eye with single retinal lesions and 
poor levels of acuity were observed in patients with macular lesions or significant 
vitris. In some cases, depending on the location and kind of damage, vision may 
be improved by administration of anti-inflammatory drugs such as clindamycin or 
prednisone. It was estimated that 0.26–0.69% of infected individuals presented 
with retinitis at the outbreak [Burnett et al., 1998]. Another study followed 25 
children with diagnosed congenital toxoplasmosis. Eighteen children (72.00%) 
developed at least one lesion, 13 children (52.00%) new central and 11 children 
(44.00%) peripheral lesions. Fifty-two per cent had new (activated) lesions after 
10 years [Phan et al., 2008]. Some researchers suggest that certain unusually viru-
lent strains of T. gondii are the prime cause of OT in the US and South America, 
where OT is a big problem in parts of Brazil [de Moura et al., 2006; Khan et al., 




Brazil and Europe concluded that children in Brazil developed retinochoroidal 
lesions earlier. They had a greater risk of multiple recurrences and large lesions 
than European children [Gilbert et al., 2008]. 
The immune status of infected patients is also of importance for the out-
come of the disease. More severe complications, such as encephalitis and OT 
were observed in HIV-infected patients [Luft and Remington, 1992; Mariuz and 
Luft, 1992; Rabaud et al., 1994]. Other cases of cerebral toxoplasmosis were ob-
served in patients with common variable immunodeficiency (CVID) ([Holtkamp 
et al., 2004] and in transplantation patients ([Hommann et al., 2002]. Again, in 
such patients high prevalences of virulent T. gondii strains were observed [Khan 
et al., 2005a]. 
Behavioural disorders represent another feature of toxoplasmosis. Many 
studies report a higher T. gondii prevalence in patients with schizophrenia com-
pared with control patients [Alvarado-Esquivel et al., 2011; Arling et al., 2009; 
Fekadu et al., 2010; Niebuhr et al., 2008; Xiao et al., 2009]. Individuals with la-
tent T. gondii infections show different personality profiles than those without 
infection. Studies from the Czech Republic suggest that infected men had a lower 
rule consciousness and were more likely to be jealous whereas the opposite was 
true for T. gondii infected women [Flegr and Havlicek, 1999; Flegr, 2010]. In an-
imals infected with T. gondii, the risk perception and novelty seeking is increased 
[House et al., 2011; Vyas et al., 2007; Webster et al., 2006; Webster, 2007]. 
However, whether T. gondii is the prime cause of such condition remains contro-
versial since other studies found no correlation between seroprevalence and schiz-
ophrenia [Hinze-Selch et al., 2007; Hinze-Selch et al., 2010]. Different mecha-
nisms have been postulated to explain these conditions which include cyst 
formation in certain areas of the brain or induction of host immune responses. 
However, psychiatric disorders were not shown to be more prevalent in areas with 




1.4 T. gondii population structure and genotypes 
As already mentioned, T. gondii has not only the capacity to propagate 
asexually but also sexually in its feline definitive host. Therefore sexual recombi-
nation should provide for a high genetic diversity between T. gondii strains 
worldwide. In contrast to this hypothesis, only a small number of T. gondii strains 
dominate in North America and Europe. First evidence of the existence of differ-
ent strains came from isoenzyme analysis of 35 French isolates [Darde et al., 
1992]. It was hypothesised that only three types of T. gondii existed, a hypothesis 
that was later confirmed with the advent of genetic analysis techniques, such as 
Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-
RFLP). T. gondii from North America and Europe fell into three genotypes, 
termed type I, type II and type III [Howe and Sibley, 1995; Sibley and Boothroyd, 
1992b]. Interestingly, type I was more virulent in mice than types II or III [Howe 
et al., 1996]. Analysing individual genes, such as GRA6 showed little variation 
between the isolated types [Fazaeli et al., 2000; Grigg and Boothroyd, 2001]. 
However, in these early studies only a limited number of loci (markers or genes) 
were analysed, so that the first South American isolates from chicken also fell into 
one of those three distinct types [Dubey et al., 2002]. Interestingly, microsatellite 
analysis of different types identified highly polymorphic loci due to its higher 
resolution [Ajzenberg et al., 2002a; Blackston et al., 2001] leading to the hypoth-
esis that all three types might have had a recent origin. Large scale sequencing of 
Expressed Sequence Tags (ESTs) discovered new genes and Single Nucleotide 
Polymorphisms (SNPs). These are small changes in the nucleotide sequences be-
tween different types of T. gondii [Ajioka et al., 1998; Manger et al., 1998]. Using 
sequencing techniques, the first analysis of North American and Brazilian T. 
gondii strains discovered a different genetic composition of South American iso-
lates. Such genetic differences were believed to be the reason for the unusually 
high frequency of severe ocular toxoplasmosis in Brazil. Furthermore, the linkage 
disequilibrium was high in North American strains which indicated a higher rate 




Brazilian strains was believed to be the result of higher rates of transmission and 
thus higher rates of outcrossing event (sexual recombination) [Lehmann et al., 
2004]. Microsatellite analysis of South American isolates showed, for the first 
time, highly diverse and distinct patterns from European and North American T. 
gondii [Ajzenberg et al., 2004]. A major break-through included the generation of 
genetic crosses between different types of T. gondii using drug resistant strains. 
Analysing the crosses of type II and type III [Sibley and Boothroyd, 1992a], type I 
and type III [Su et al., 2002] as well as newly identified markers led to the first 
composite genetic map of T. gondii which provided the framework for further 
genetic studies. It not only identified three new chromosomes, bringing the total 
number of chromosomes (Chr.) to 14 (Chr. Ia, Ib, II, III, IV, V, VI, VIIa, VIIb, 
VIII, IX, X, XI and XII) but also showed that several chromosomes showed ho-
mologous type specific patterns. Chr. IV was shown to have exclusively type II 
specific SNPs whereas Chr. XI consisted primarily of type I specific SNPs [Khan 
et al., 2005b]. Further analyses of genetic sequences of different T. gondii strains 
from humans and animals from France and the USA discovered that Chr. Ia was 
shared between all type I and type II T. gondii [Khan et al., 2006a]. Closer analy-
sis of Chr. Ia discovered that this Chr. was very similar or identical in all three 
types and thus inherited in common by all three types about 10,000 years ago [Su 
et al., 2006]. Furthermore, 4,324 SNPs were identified among the three types, 
using new EST data. It became clear that large chromosomal regions were domi-
nated by one of the three type specific SNPs. For example 98.00% of Chr. XI con-
tained type I SNPs whereas 90.00% of Chr. IV was dominated by type III SNPs. 
Since some Chr. (except for Chr. Ia) contained only a maximum of two different 
type specific SNPs and clear transition points between those specific SNPs exist-
ed, it was hypothesised that the present T. gondii types must have originated by 
recombination of only a few of ancestral crosses. The fact that polymorphic pat-
terns between type I and type III SNP regions and high levels of atypical SNPs in 
type II dominated region existed lead to the theory that two separate crossing 




must have occurred. A diagram of the proposed models is shown in Figure 2. Ac-
cording to this model, type II parental strains (which are not very similar to each 
other) are divergent from strain α and strain β. Strains α and β are distinct from 
each other but closer related to each other than to type II. According to this model, 
a cross between an ancestral type II and α led to the modern-day type I and a cross 
between an ancestral type II and β produced the modern-day type III. A type II 
ancestor similar to the other type II ancestors leading to the emergence of modern-
day types I and III was involved in the emergence of the present-day type II 
strains. Due to the criteria of the chromosomal SNP patterns under such model, 
the isolate P89 was postulated to be strain β. [Boyle et al., 2006]. Newly discov-
ered loci lead to a widespread use of nine PCR-RFLP markers, called newSAG2 
(Chr. VII), SAG3 (Chr. XII), BTUB (Chr. IX), GRA6 (Chr. X), c22-8 (Chr. Ib), 
c29-2 (Chr. III), L358 (Chr. V), PK1 (Chr. VI) and Apico (extra chromosomal) for 
genotyping T. gondii isolates worldwide. Genotyping progressed from looking at 
only one or four single loci to analysing nine unlinked, independent loci thus in-
creasing resolution [Su et al., 2006]. 
 
Figure 2: Proposed model of inheritance creating the present-day T. gondii genotypes.  





The isolation of more South American strains from Brazil showing a PCR-
RFLP pattern previously not observed in types I, II and III, termed “atypical” iso-
lates facilitated in depth research into the population structure of T. gondii [Su et 
al., 2006]. By analysing 275 isolates from free-ranging chickens collected from all 
over the world, the first comprehensive population study was conducted using five 
Short Tandem Repeats (STRs) loci, one microsatellite and the SAG2 locus. In this 
study, two South American populations of high genetic diversity were identified, 
as well as extensive genetic differences in T. gondii isolates from the new and the 
old world. While North American isolates closely resembled the European isolates 
(old world), African isolates clustered in between old and new world isolates. Us-
ing a bayesian statistical model, i.e. the program STRUCTURE, only four popula-
tions of T. gondii were identified. Two genetically diverse populations were con-
fined to South America (SA1 and SA2), another population showing small genetic 
differences was situated in Europe, North America, Asia and Africa (RW) whereas 
the fourth population showed cosmopolitan abundance (WW). Some strains 
spread globally within a short period of time as evident from mutational distances 
among them. Therefore long-term isolation and extensive migration of T. gondii 
must have played major roles. South America was concluded to be the birthplace 
of modern-day T. gondii strains followed by two migration events into North 
America and Europe. One migration event must have taken place in Eurasia pos-
sibly mediated by man. Ships, carrying T. gondii infected intermediate host spe-
cies such as mice and rats into Eurasia have been proposed as one possible route. 
The second migration event was postulated to have occurred as part of the global 
maritime sea trade which included food stuff, livestock, cotton and slaves. This 
could have dispersed the RW population to other continents where no T. gondii 
population was established at that time. Increased trade was proposed to have led 
to the establishment of the WW population even into areas that were already in-
habited by T. gondii [Lehmann et al., 2006]. Interest in the population structure of 
T. gondii grew with the identification of new South American isolates and new 




unlinked loci and Chr. Ia, it was further confirmed that there was segregation be-
tween strains from South America and Europe/North America. All 46 strains used 
in the study were grouped into 11 distinct haplogroups. Haplogroups 1–3 (contain-
ing types I, II and III, respectively) originated exclusively from Europe and North 
America whereas haplogroups 4, 5 and 8–10 occurred only in South America. 
Haplogroup 6, however, was found to be wide spread in Europe, North America, 
South America and Africa. Genotypes that were termed “atypical” because they 
showed an unknown PCR-RFLP pattern at some loci were found to be common in 
South America. Collectively, the data suggested that European/North American 
strains diverged from South American strains approximately 1,000,000 years ago, 
but that a small number of types (I, II and III) must have rapidly expanded within 
the past 100,000–10,000 years. It was postulated that an admixture of four ances-
tral lineages, similar to haplogroups 2, 4, 6 and 9 had resulted in the 11 haplog-
roups. If the apicoplast, a secondary endosymbiont that is only inherited maternal-
ly [Ferguson et al., 2005] is taken into account, haplogroups 1, 2, 4 and 8 must 
have derived from a different matrilineage than haplogroups 3, 6 and 9 [Khan et 
al., 2007]. Closer examination of South American isolates confirmed that such 
atypical strains were genetically highly diverse and common in Brazil. It was also 
discovered that within South America some strains were more common than oth-
ers and formed distinct clonal groups different from types I, II and III that ap-
peared in North America and Europe. The Brazilian clonal types were termed BrI, 
BrII, BrIII. Even more interesting members within the clonal groups showed dif-
ferent virulence in mice. Type BrI was highly mouse-virulent and truly “atypical”, 
whereas types BrII and BrIII were non-virulent in mice and showed a combination 
of alleles specific for types I, II and III at different loci. Such strains are now re-
ferred to as non-canonical T. gondii and were postulated to have recently expand-





Other genotypes, different from types II and III were also discovered in Af-
rica [Velmurugan et al., 2008]. The discovery of a T. gondii strain from Uganda 
showed that recombination events between T. gondii strains have occurred in Af-
rica. In addition new SNPs, i.e. SNPs not common in European and North Ameri-
can strains, were identified in Ugandan type II (UgII) and type III Ugandan 
(UgIII) strains. Furthermore, it was shown that such type III isolates from Uganda 
differ in their virulence from European/North American type III. SNP data sug-
gested that the age of the most recent ancestor (MRCA) of UgII and type II (Eu-
rope) was 17,400 years, whereas the divergence of the UgII isolate from type III 
was 9,200 years. UgII was found to be more divergent from the European and 
North American type II than UgIII from the European and North American type 
III. The recombinant strain TgCkUg2 arose by chromosomal sorting rather than 
interchromosomal recombination [Lindström Bontell et al., 2009]. New African 
haplogroups were identified in Gabon by microsatellite analysis using 13 markers. 
Cluster analysis resulted in 3 groups: group 1 included an Africa 1 haplogroup 
together with type I, group 2 included an Africa 3 haplogroup and group 3 all type 
III/type III-like strains [Mercier et al., 2010]. Even more interesting, T. gondii 
isolated from wild animals from French Guiana were highly divergent, whereas 
isolates from domestic animals in the same country in an anthropised environment 
shared their genotypes. Except for one isolate, a clear boundary was observed 
between wild and anthropised isolates indicating that two distinct T. gondii popu-
lations existed which correspond to the domestic and the wild cycle of T. gondii 
[Mercier et al., 2011].  
The current population structure of T. gondii suggests strong geographic 
segregation between the European/North American strains and the South Ameri-
can strains [Khan et al., 2011b]. It also includes the newly diverged African and 
newly identified Chinese [Zhou et al., 2010] genotypes. All strains included in 
this new analysis were characterised by sequencing eight introns on Chr. IV, VIIa, 




ters. Cluster 1 includes haplogroups 1–3, 7, 11 and 12 those isolates are found in 
Europe/North America. Cluster 2 includes haplogroups 4, 5, 6, 8, 9, 10 that con-
tain isolates from South America as well as Africa. The last two clusters consist of 
haplogroup 13 and 14 that include parasites isolated from China and Africa, re-
spectively. Interestingly haplogroups 1, 2, 3, 4, 7, 8, 9 and 13 were found to be 
highly similar for Chr. Ia. This monomorphic Chr. Ia will be referred to as Chr. Ia* 
in the following. Interestingly, haplogroups 5 and 10 (containing South American 
and African isolates) were shown to possess completely different versions of Chr. 
Ia in each isolate. Haplogroup 13 (Chinese isolates) contained only few SNPs di-
vergent from Chr. Ia* and also clustered with other Chr. Ia haplogroups. Regard-
ing Chr. Ia, haplogroup 6 clustered with haplogroup 14 (African isolates) and had 
a Chr. Ia divergent from Chr. Ia* at the 3’ end (3’ chimeric Chr. Ia), whereas hap-
logroups 11 and 12 (isolated from wild animals from North America) showed a 
Chr. Ia divergent from Chr. Ia* at the 5’ end (5’ chimeric Chr. Ia) [Khan et al., 
2011b]. Interestingly, haplogroup 12 had only been discovered recently as a fourth 
clonal lineage in North America and was found to be restricted to wild animals 
[Khan et al., 2011a]. Analysis of Chr. Ia of haplogroups 11 and 12 indicated a sin-
gle meiotic recombination in the wild. According to the SNPs found in intron se-
quences, North American/European T. gondii split from South American lineages 
approximately 100,000 years ago, while North American and European strains 
separated approximately 10,000 years ago. Haplogroup 12 is postulated to be the 
most likely parent that led to the type II observed today. Large blocks of type III 
SNPs on Chr. Ia were shared in haplogroup 9 whereas large blocks of type I SNPs 
were shared on Chr. Ia in haplogroup 6. The age of the respective groups are con-
sistent with the hypothesis that ancestors of haplogroup 9 led to the formation of 
haplogroup 3 (type III) and that ancestors of haplogroup 6 led to the formation of 
haplogroup 1 (type I). Therefore ancestral members of haplogroup 9 (e.g. the P89 
isolate) could be the proposed factor ß and ancestral isolates of haplogroup 6 (e.g. 
the FOU isolate) might be closely related to the ancestral strain α providing the 




logroups under the proposed model of Chr. Ia is given in Table 5 [Khan et al., 
2011b].  
As already mentioned, North America and Europe are dominated by types I, 
II, III. Although all three clonal types are observed in Europe to a certain extent, 
not all types are evenly distributed or found in all countries and in all infected 
species. In Germany, most isolates found until 2007 were derived from feline fae-
cal samples but were almost exclusively of type II [Schares et al., 2008b]. Type I 
was not detected when 20,317 feline faecal samples were examined. In fact, most 
isolates obtained until 2007 showed a high prevalence of genotype II in Europe. In 
Austria, 830 chickens were analysed and 67 T. gondii isolates recovered by bioas-
say in mice. Genotyping performed only at the SAG2 locus, resulted in T. gondii 
of type II in all cases [Dubey et al., 2005a]. In the arctic (Norway), the majority of 
analysed foxes were found to be infected with T. gondii type II. Only four foxes 
(7.30%) were infected with type III, while type I was not found. However, 
40.00% of T. gondii-DNA from foxes could not be fully genotyped and the T. 
gondii of two (3.60%) foxes shared more than one allele at a given locus or 
showed different type-specific alleles over ten loci [Prestrud et al., 2008]. Fur-
thermore, a number of T. gondii isolates from Portugal and Spain showed a high 
proportion of T. gondii type III [Dubey et al., 2006e; Montoya et al., 2008; Waap 
et al., 2008]. In contrast, T. gondii isolated from chickens in Poland showed that 
atypical T. gondii were found in Europe [Dubey et al., 2008b]. Genotyping results 








Table 5: Haplogroups of T. gondii isolated world-wide.   
 [Khan et al., 2011b] - modified. 
Eur: Europe; N-A: North America; S-A: South America; Afr: Africa; As: Asia; a: factor α; b: factor β; c: 
ancestral type II 
Haplo-
group 









1 Eur, N-A type I Yes    
2 Eur, N-A type II Yes    
3 Eur, N-A type III Yes    
4 S-A MAS Yes    
5 S-A Guy    Yes 
6a Eur, N-A,  
S-A, Afr 
FOU, Africa 1 isolates  Yes   
7 Eur, N-A CAST Yes    
8 S-A TgCatBr6 Yes    
9b Eur, N-A,  
S-A 
P89, TgCatBr10 Yes    
10 S-A VAND    Yes 
11 N-A TgCgCa1   Yes  
12c Eur, N-A TgSoUs13 Yes  Yes  
13 As TgCtPRC2 Yes    


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Few analyses of human congenital toxoplasmosis exist for Europe. They 
showed that the majority of clinical cases are caused by T. gondii of type II but 
that type I and type III have nevertheless been found in humans all over Europe 
[Ajzenberg et al., 2002a; Aspinall et al., 2003; Fuentes et al., 2001; Honore et al., 
2000; Howe et al., 1997; Nowakowska et al., 2006] as shown in Table 7. In hu-
man clinical cases with immunosuppression, similar genotypes prevail. However, 
in contrast to congenital human cases, more type I and type III T. gondii were ob-
served in these patient groups [Aspinall et al., 2003; Fuentes et al., 2001; Honore 
et al., 2000; Howe et al., 1997] as shown in Table 8.  
Regarding T. gondii genotypes associated with ocular toxoplasmosis, very 
few studies exist. Using five loci (SAG1, SAG2, SAG3, SAG4 and B1) to analyse 
twelve clinical cases of ocular toxoplasmosis in the USA, three cases were identi-
fied as T. gondii type I, three were of type II and only one was of type III. The 
five remaining T. gondii isolates were of non-canonical or atypical genotypes 
[Grigg et al., 2001b]. Genotyping of T. gondii isolated from a Korean patient with 
ocular toxoplasmosis identified T. gondii type I [Quan et al., 2008]. SNP analysis 
of a repetitive polymorphic region of the non-transcribed spacer 2 (NTS2) located 
between the 28S and 18S rRNA genes demonstrated that all from Poland were 
infected with T. gondii of type I [Switaj et al., 2006]. However, since comparisons 
with more established genotyping techniques were not carried out, it is difficult to 
interpret the results of this study. Unfortunately, no studies exist on T. gondii gen-
otypes in humans from Germany. 
Compared to South America, the genetic diversity of T. gondii in animals 
and humans in Europe and North America is low. Genotyping of animals in South 
America revealed that the majority of T. gondii isolates from free-ranging chick-
ens in Nicaragua, Brazil, Chile, Colombia and Guyana harboured a high number 
of non-canonical and atypical T. gondii [Dubey et al., 2005b; Dubey et al., 2006b; 
Dubey et al., 2006d; Dubey et al., 2007a; Dubey et al., 2008e]. Other genetically 




etnam, Colombia and Sri Lanka [Dubey et al., 2007b; Dubey et al., 2007c; Dubey 
et al., 2007d; Dubey et al., 2007e] as well as cats from China [Dubey et al., 
2007h] and Brazil [Pena et al., 2008]. Other atypical T. gondii isolated were ob-
served in a toxoplasmosis outbreak in Surinam and in wild jaguars in French Gui-
ana [Demar et al., 2007; Demar et al., 2008]. Genotypic analysis of immunocom-
promised humans with toxoplasmosis from Brazil using three loci revealed that 
40/87 (45.98%) patients were infected with T. gondii type I, 9/87 (10.35%) with 
type II and 4/87 (4.60%) with type III. The remaining patients showed T. gondii 
of a polymorphic allele pattern (19/87; 21.83%) or their genotype could not be 
determined (15/87; 17.24%) [Ferreira et al., 2008; Ferreira et al., 2011].  
In contrast, T. gondii observed in pigs and sheep from the USA were mostly 
of type II or III and only a few T. gondii showed a non-canonical or atypical allele 
pattern [Dubey et al., 2008a; Dubey and Jones, 2008; Dubey et al., 2008d]. Sur-
prisingly, T. gondii from wild mammals, such as skunk, black bear, racoon and 
sea otters from the USA were shown to be of non-canonical types [Dubey et al., 
2008c; Miller et al., 2008]. 
 
1.5 T. gondii virulence and virulence factors 
First experiments with T. gondii types I, II and III showed that type I was 
highly virulent for outbred mice. Acute infection with type I (RH) was not dose-
dependent and resulted always in the death of all infected mice. The lethal dose 
(LD), which resulted in 100 per cent death in a group of mice, was equal to one 
parasite (LD100 = 1). In contrast, infection with type II (ME49) or III (CEP, NED) 
had a reduced virulence with an LD50 > 103 parasites [Howe et al., 1996; Sibley 
and Boothroyd, 1992b]. Infection with T. gondii regardless of the type was shown 
always to result in a loss of weight in mice. However, the onset of the response 




clonal type I resulted in an earlier and more pronounced weight loss than observed 
in mice infected with types II or III. Also, mice infected with types II or III always 
showed a period of weight gain after initial weight loss, but never reached their 
pre-infection weight [Jensen et al., 1998a]. Most data on virulence was estab-
lished in mice. However, a T. gondii of type III (O14) isolated from abortive sheep 
showed no adverse effects in mice but resulted in high virulence when used for 
infection in pigs [Jungersen et al., 1999; Jungersen et al., 2002]. Thus, virulence 
seems be influenced by both host and parasite factors. In contrast, most humans 
infected in Europe were shown to be infected with T. gondii type II and only a few 
infections with type III were reported (see previous section). It was therefore ar-
gued that human T. gondii infections simply reflect the presence of T. gondii geno-
types in the respective animal reservoir [Boothroyd and Grigg, 2002]. 
Interestingly, most type I T. gondii strains used to date in experimental stud-
ies were isolated from a humans (RH) or goats (GT1) a number of decades ago. It 
has therefore been suggested that continued laboratory passage of these strains, 
e.g. the RH strain, may have led to increased virulence. However, it was shown 
that all different RH strains existing in laboratories with varying passage numbers 
resemble in their virulence pattern to mice [Su et al., 2002] and possess similar 
growth properties and gene expression levels. Other researchers observed differ-
ences in the multiplication and growth rate between the different types of T. 
gondii. Again, type I showed increased doubling times as compared to types II 
and III [Radke et al., 2001]. Enhanced migration, together with higher growth 
rates, leading to increased dissemination, a more rapid growth and a higher tissue 
burden, induced proinflammatory mediators resulting in more pronounced pathol-
ogy [Barragan and Sibley, 2002; Barragan et al., 2005; Gavrilescu et al., 2004]. 
Immunological investigations revealed that T. gondii elicits a Th1 response 
during and after entry of T. gondii into host cells. This response is characterised by 
an increased interferon-gamma (IFN-γ), tumour necrosis factor-alpha (TNF-α), 




cells. Upon infection with T. gondii, APCs recognise surface antigens via toll-like 
receptors (TLRs) and pathogen associated molecular patterns (PAMPs). Activa-
tion of such receptors starts a cascade that culminates in the activation and trans-
location of nuclear factor-kappa B (NF-kB) to the nucleus of the APC and tran-
scription of pro-inflammatory responses such as IL-12. Released IL-12 can 
activate other immune cells such as natural killer cells (NKs) or T-cells leading to 
a secretion of further inflammatory mediators such as IFN-γ. IFN-γ can then bind 
to its receptors on infected cells activating the janus kinase/signal transducer and 
activator of transcription (JAK/STAT) pathway, leading to the phosphorylation of 
STAT1 which is translocated to the nucleus. This leads to the transcription of IFN-
γ-stimulated genes such as interferon regulated factor 1 (IRF1), class II Major 
Histocompatibility Complex (MHC) and interferon regulated GTPases (IRGs). 
IRGs were shown to accumulate on the PVM in infected cells, leading to IRG-
dependent killing of T. gondii [Melo et al., 2011]. 
The process of translocating NF-kB to the host cell nucleus was shown to be 
strain-dependent. While infection with T. gondii types II and III led to a transloca-
tion of NF-kB, infection with virulent T. gondii type I did not. Furthermore, IL-12 
release seemed to be initiated by type II, but not by type I. However, antigens iso-
lated from the respective types alone did not elicit any IL-12 release in neutro-
phils. Therefore, an active penetration or infection was needed to elicit any host 
cell response [Denkers et al., 2004; Robben et al., 2004]. 
After the first genetic crosses between types II and III, as well as between 
types I and III had been generated [Grigg et al., 2001a; Su et al., 2002], mouse 
virulence and its determinants were investigated. A cross between the two aviru-
lent T. gondii types II (PTG) and III (CTG) surprisingly revealed that offspring of 
the F1 generation was of higher virulence in mice than either of the parental 
clones [Grigg et al., 2001a]. The same phenomenon was observed in crosses be-
tween the virulent type I (GT-1) and the avirulent type III (CTG). This cross al-




lence in the progeny. QTL-analysis revealed that an increased virulence was 
strongly linked to a region on Chr. VII with a minor contribution from Chr. Ib and 
IV [Su et al., 2002]. Genetically engineered strains of the T. gondii type IIxIII 
cross expressing luciferase confirmed that the more virulent strains had a higher 
growth rate in mice and disseminated better in mouse tissue as compared to less 
virulent strains [Saeij et al., 2005].  
The progeny of crosses between the respective types were further assessed 
by QTL-analysis of total RNA isolated from the progeny against a cDNA library 
of type I (RH). Applying 175 genetic markers used for mapping the genome 
[Khan et al., 2006a] identified five virulence regions associated with virulence in 
the T. gondii progeny. The VIR1 region included the candidate genes ROP5 and 
SAG3 on Chr. XII, while VIR2 indicated that unidentified genes on Chr. X were 
linked to virulence. VIR3 identified ROP18 on Chr. VIIa, VIR4 was associated 
with ROP16 on Chr. VIIb and VIR5 included an adenosine kinase on Chr. XII 
[Saeij et al., 2006]. The strongest candidate for a virulence factor was ROP18 as it 
has been shown to be recruited to the surface of the PVM. Furthermore, analysis 
of gene expression showed that type III expressed considerable less ROP18 than 
types I or II. Sequencing of ROP18 revealed that type III had a 2.1-kilobase se-
quence inserted upstream of the start of the ROP18 gene. Introducing the ROP18 
allele of type II (ROP18II) into a type III background resulted in a 4-log increase 
of virulence compared to the wild-type type III [Saeij et al., 2006]. When ROP18I 
was introduced into a type III background and inoculated into mice, a 4-fold in-
crease in the number of parasites per vacuole was observed. Furthermore, viru-
lence in mice increased 5-fold compared to type III. ROP 18 was further described 
as a pseudokinase. A point mutation introduced into ROP18I which disrupted its 
active site showed that the kinase activity is required for mediating enhanced viru-
lence [Taylor et al., 2006]. Comparing VIR4 between different types of T. gondii, 
which identified ROP16 on Chr. VIIb, it became apparent that ROP16II had 39 
non-synonymous SNPs as compared to ROP16I and ROP16III. Incorporation of 




strain-specific activation of STAT3/6 and thus IL-12 secretion. In contrast to wild-
type type II, type II:ROPI  induced STAT3 phosphorylation and thus inhibited IL-
12 expression in infected HFF cells. The results provided a molecular basis for the 
strain-dependent differences in host cell responses to T. gondii infections. Type II, 
but not type I or III strains induced mouse macrophages to produce high levels of 
IL-12 to combat T. gondii infection [Saeij et al., 2007]. All these studies were 
carried out in the light of the three major types existing in Europe and North 
America. However, descriptions of highly virulent T. gondii showing an atypical 
allele pattern by PCR-RFLP [Demar et al., 2008; Dubey et al., 2006a; Dubey et 
al., 2008b; Pena et al., 2008] and the first reports of clonal lineages from Brazil, 
which showed different virulence but were genetically distinct from types I, II and 
III, illustrated that further studies on the previously described virulence markers 
were needed. The newly discovered Brazilian T. gondii isolates of clonal group 
BrI displayed high virulence in mice, BrII showed intermediate virulence whereas 
T. gondii of group BrIII showed no virulence in mice. Importantly, many isolates 
displaying atypical alleles had low virulence in mice [Pena et al., 2008]. Analysis 
of 25 T. gondii isolates representing 11 haplogroups were analysed for their 
ROP18 genetic diversity within eight introns from five unlinked loci. The results 
showed that, despite the high genetic diversity between haplogroups, only three 
alleles of ROP18 existed, named ROP18I*, ROP18II* and ROP18III* that corre-
sponded to the different alleles previously described in types I, II and III. Never-
theless the genetic diversity in ROP18 was greater than in other T. gondii proteins 
such as SAG1, SAG2 or GRA3. Furthermore, ROP18 had a higher level of non-
synonymous polymorphisms (pNS), i.e. these are base substitutions that might 
lead to missense or non-sense mutations, than surface antigens or house-keeping 
genes, which had mostly synonymous polymorphisms (pS). An elevated ratio of 
pNS/pS was detected in ROP18 suggesting a selective pressure on ROP18. Ex-
pression analysis between different isolates further showed an increased expres-
sion of ROP18 in isolates carrying ROP18I* as compared to ROP18III*. Howev-




high expression. Sequencing of ROP18 in different clonal types confirmed the 
presence of a 2.1 kb insert upstream of ROP18 (UPS-ROP18) in ROP18III* iso-
lates. The presence or absence of UPS-ROP18 can be detected by conventional 
PCR. Furthermore, almost all avirulent T. gondii isolates analysed had the UPS-
ROP18, whereas UPS-ROP18 was absent in virulent isolates carrying ROP18I*, 
but also in those with ROP18II*. Comparison of ROP18 in T. gondii with the 
closely related protozoan N. caninum revealed the existence of UPS-ROP18 simi-
lar to ROP18III* isolates [Khan et al., 2009]. Both protozoans were shown to 
share a common ancestor [Su et al., 2003] which led to the hypothesis that the 
UPS-ROP18 was lost by deletion or rearrangement in the more recent ancestors of 
ROP18I* and ROP18II*. Seventeen of 18 ROP18I* carrying isolates were viru-
lent in mice, while 6/8 ROP18III* carrying T. gondii isolates were avirulent. In-
terestingly, high-virulent isolates carrying ROP18III* (CASTELLS and P89) 
showed no difference to the UPS-ROP18, and the coding sequence of ROP18 did 
not differ between isolates of the same group. Therefore, other genetic factors 
must confer virulence in these isolates [Khan et al., 2009]. 
ROP18 was shown to promote the growth of T. gondii in inflammatory 
monocytes. While type I expressing ROP18 (ROP18I) underwent rapid expansion 
in the peritoneum of infected mice, type III T. gondii remained at background lev-
els. Further analysis showed that ROP18I parasites resided in intact vacuoles while 
ROP18III were associated with highly damaged vacuoles that underwent destruc-
tion. Introduction of ROPI into a type III background showed that ROP18 was 
associated with the recruitment of IRGs. The level of ROP18 on vacuoles of 
ROPI:type II parasites was inversely correlated with Irgb6 staining, which sug-
gested that high level expression of ROP18 blocked recruitment of IRGs. Further 
experiments showed that ROP18 co-precipitated with Irgb6 and that active 
ROP18 was able to phosphorylate Irgb6 and Irgb10 in activated monocytes. Stud-
ies using small interfering RNAs (siRNA) to knock out Irgb6 resulted in the inhi-
bition of ROP18-knockout parasite clearance thus reversing the effect shown in 




was associated with the ability to phosphorylate IRGs and thus prevented parasite 
clearance by macrophages [Fentress et al., 2010]. Another target of ROP18 was 
discovered to be the host endoplasmic reticulum-bound transcription factor 
ATF6β. ROP18 binds to the C-terminal of ATF6β and triggers degradation of the 
transcription factor [Yamamoto et al., 2011]. 
 
Several researchers recently identified an additional virulence factor corre-
sponding to VIR1 on Chr. XII. A ROP5 coding sequence was initially identified 
as the potential single locus conferring virulence but was later shown to be a clus-
ter of tandemly repeated genes coding for this kinase. Type I has 6, type II 10 and 
type III has 4 tandem copies of the ROP5 pseudokinase gene. Also, all clonal 
types have three major isoforms of this pseudokinase, A, B and C. However, the 
ROP5 gene clusters of type I and type III were shown to be nearly identical and 
possess, in contrast to type II, virulent gene versions of ROP5. A frameshift in 
type II ROP5B seemed to result in a non-functional protein. However, the in-
creased copy number appears to compensate for the defective version. ROP5-
knockout parasites (ΔROP5) were used to discover which isoforms were needed 
to increase the virulence of T. gondii for mice. Insertion of a single copy of iso-
form ROP5AIII into ΔROP5 restored virulence. It was further increased by insert-
ing two copies of ROP5AIII into ΔROP5 and insertion of a single copy of 
ROP5AIII and ROP5BIII. However deletion of ROP5 had a more pronounced ef-
fect on virulence than deletion of ROP18. It has therefore been suggested that 
ROP5 acts independently of ROP18 and ROP16 [Behnke et al., 2011; Ong et al., 
2010; Reese and Boothroyd, 2011; Reese et al., 2011].  
Other research on ROP16 indicated that its kinase activity is essential for 
STAT3 activation and that a single amino acid polymorphism determines the po-
tency of the activation. This was proven by generating ROP16-deficient type I 
parasites which showed a marked reduction in STAT3 activation resulting in in-
creased IL-12 production in infected macrophages. This defect was fully restored 




the ROP16 gene is responsible for STAT3 activation and thus for the suppression 
of T. gondii-induced inflammatory cytokines [Yamamoto et al., 2011].  
 
1.6 Aim of the study 
To date, there is only limited data available concerning T. gondii genotypes 
in Germany. Preliminary studies indicated a high prevalence of type II in Europe-
an countries including Germany. It has been shown, however, that other genotypes 
circulate in countries bordering Germany, such as Poland. No data existed on T. 
gondii genotypes in humans for Germany. To describe the genetic diversity of T. 
gondii in Germany, feline faecal samples were examined for the presence of T. 
gondii oocysts. Oocysts were isolated and genotyped using nine genetic markers. 
Isolated oocysts were bioassayed in mice and further propagated in-vitro. In-vivo 
experiments were conducted to examine the virulence of these T. gondii field iso-
lates. To identify T. gondii genotypes in humans, vitreous fluid from patients with 











2 Materials and Methods 
2.1 Animal models 
IFN-γ knockout (GKO) mice (C.129S7(B6)-Ifngtm1Ts/J) were purchased 
from The Jackson Laboratory (Bar Harbor, Maine, USA), bred at the Friedrich-
Loeffler-Institut and used to obtain T. gondii isolates from oocysts. 
BALB/c mice (BALB/cAnNCrl) were purchased from Charles River (Sul-
zfeld, Germany), bred at the Friedrich-Loeffler-Institut and used for in-vivo viru-
lence studies. 
All mice were housed in standard cages and handled according to national 
guidelines. All animal experiments were approved by the Ministerium für Land-
wirtschaft, Umweltschutz und Raumordnung of the German Federal State of 
Brandenburg. 
2.1.1 GKO mouse infection with sporulated oocysts 
Prior to inoculation, oocysts kept in K2Cr2O7 solution were washed four 
times by centrifugation (1,100 x g, 7 min, without brake) and resuspended in 15 
ml tap water. The resulting pellet was finally resuspended in 1 ml tap water. Spor-
ulated oocysts were counted using a Neubauer chamber. GKO mice were infected 
by oral gavage with 103 sporulated oocysts in a volume of 0.2 ml. When first clin-







2.1.2 T. gondii virulence studies in BALB/c mice 
Two to three months old BALB/c mice were used in all experiments. For in-
tra-peritoneal infection, tachyzoites were grown and extracted from host cells by 
passage through a 27-gauge needle, washed twice in RPMI and quantified using a 
Neubauer chamber. Parasites were diluted in RPMI, and groups of five mice per 
dose inoculated intraperitoneally with 106, 104, 102 or 10 tachyzoites of each clone 
(in 500 µl) using a 27G needle. Each in-vivo experiment was carried out alongside 
a negative control group inoculated with RPMI only. Weight and mortality of the 
animals were daily recorded for 30 days after infection. Blood samples were taken 
at 0, 7, 14, 21, 28 and 30 d.p.i.. Mice were sacrificed at more than 20 per cent 
weight loss. All animals were necropsied and their organs weighted.  
 
2.2 Molecular methods 
2.2.1 DNA isolation 
2.2.1.1 Oocyst-DNA 
DNA was extracted from oocysts as described previously [Schares et al., 
2008b]. Briefly, oocysts stored in 1–2% K2Cr2O7 were washed four times by cen-
trifugation (1,100 x g, 7 min, without brake) in 15 ml PBS. The pellet, containing 
oocysts and remaining contaminants, was incubated in 2 ml 4% NaOCl (30 min, 
37°C), then filled up to 12 ml with double-distilled H2O and centrifuged (1,100 x 
g, 7 min, without brake). The pellet was resuspended and washed three times with 
PBS (1,100 x g, 7 min, without brake). After the last washing step, the pellet was 
transferred into a 1.5 ml reaction tube and subjected to three freeze (-20°C, 10 
min) / thaw (room temperature, 2 min) cycles. It was then resuspended and incu-
bated in 100 µl OOC-lysis buffer (600 mM EDTA, 1.3% (v/v) N-lauroylsarcosine, 
2 mg/ml Proteinase K) for 45 min at 65°C. Thereafter, 400 µl OOC-CTAB buffer 
(2% (w/v) cetyl-trimethyl ammonium bromide, 1.4 M NaCl, 0.2% (v/v) mercap-




ed and the suspension incubated for 60 min at 60°C. DNA was extracted with 500 
µl phenol/chloroform/isoamylalcohol (in a 25:24:1 ratio) until the supernatant was 
without visible contaminants and collected into a fresh 1.5 ml reaction tube. After 
the addition of 0.04 vol of 4 M NaCl, the DNA was precipitated with 2 vol abso-
lute ethanol, washed once with 70% (v/v) ethanol, dried and resuspended in 100 
µl sterile double-distilled water. DNA was stored at 4–8°C until analysed. Ali-
quots of 1–2.5 µl were used for PCR. 
2.2.1.2 Tachyzoite-DNA 
DNA was extracted from pellets of in-vitro grown tachyzoites using a com-
mercial kit (NucleoSpin® Tissue, Macherey-Nagel, Germany) according to the 
manufacturer’s instructions. 
2.2.1.3 DNA from tissue samples 
Tissue samples were collected and 100 mg weighed up for DNA isolation. 
DNA was isolated from the tissue samples using a standard protocol with some 
modifications [Strauss, 2001]. Briefly, tissue was digested overnight at 55°C in 
600 µl lysis buffer (7.5 M ammonium acetate, 25 mM ethylene diamine tetra ace-
tic acid (EDTA), 0.5% sodium dodecyl sulphate (SDS), 10 mM Tris pH 8.0 (Sig-
ma, Germany), 0.2 mg/ml Proteinase K (Applichem, Germany)) shaking continu-
ously in a thermo mixer (Eppendorf, Germany). DNA was extracted with 600 µl 
phenol/chloroform/isoamylalcohol (in a 25:24:1 ratio) until the supernatant was 
without visible contaminants and collected in a fresh 1.5 ml reaction tube. After 
the addition of 0.04 vol of 4 M NaCl, the DNA was precipitated with 2 vol abso-
lute ethanol, washed once with 70% (v/v) ethanol, dried and resuspended in 100 





2.2.2 Diagnostic PCR 
For all PCR reactions, HPLC-purified primers were used at a final concen-
tration of 0.5 mM, dNTPs at a final concentration of 250 mM each (Stratec Mo-
lecular, Germany) and Taq Polymerase (Stratec Molecular, Germany) at a final 
concentration of 1 U/25 µl with the buffer system supplied with the enzyme 
(Stratec Molecular, Germany). DNA extracted from oocysts and tachyzoites was 
first analysed by PCR using the primers listed in Table 9. PCR cycling conditions 
were as follows:  
(1) COC-1/COC-2, JS4/5, Np6+/Np21+: 5 min at 94°C followed by 10 cycles of 1 
min at 94°C, 1 min at 56°C, 1 min at 72°C followed by 40 cycles of 1 min at 
94°C, 1 min at 51°C, 1 min at 72°C and a final extension of 10 min at 72°C. 
(2) TOX4/TOX5, TOX5/Tox-8: 1 min at 94°C followed by 35 cycles of 1 min at 
94°C, 1 min at 60°C, 1 min at 72°C and a final extension of 10 min at 72°C. 
(3) Hham34F/Hham3R: 1 min at 94°C followed by 35 cycles of 5 min at 94°C, 1 
min at 60°C, 1 min at 72°C and a final extension of 10 min at 72°C. 
Oocysts samples in which T. gondii was detected (i.e. amplification of the 
relevant PCR-product using TOX4/TOX5 and TOX5/Tox-8 primers) were identi-
fied and designated according to their origin. Designation was chosen as follows: 
TG-GERxxx for cats from Germany, where xxx corresponds to the isolate num-
ber. Cats from other countries were designated as TG-CCCxxx, where CCC stands 
for the 3-letter country code. T. gondii positive dog samples were designated TG-






Table 9: PCR primers used for diagnosis of DNA isolated from oocysts.  
F: forward; R: reverse 
Locus Parasite Primer Sequence (5’- 3’) Reference 







[Ho et al., 1996] 
529bp 
repeat 







[Homan et al., 2000] 
529bp 
repeat 







[Homan et al., 2000; 
Reischl et al., 2003] 







[Müller et al., 1996] 






[Slapeta et al., 2002]  





[Schares et al., 2008a] 
 
2.2.3 Genotyping by PCR-RFLP 
Genotyping was carried out using standard protocols as described 
[Herrmann et al., 2010; Su et al., 2006]. Loci of genetic marker regions were am-
plified by multiplex nested-PCR using the primers listed in Table 10. For all PCR 
reactions, HPLC-purified primers were used at a final concentration of 0.5 mM, 




Taq Polymerase (Stratec Molecular, Germany) at a final concentration of 1 U/25 
µl with the buffer system supplied with the enzyme (Stratec Molecular, Germany). 
External PCRs were performed using the following cycling conditions: 4 min at 
94°C followed by 35 cycles of 30 s at 94°C, 1 min at 55°C, 2 min at 72°C and a 
final extension of 10 min at 72°C. Internal PCRs for loci newSAG2, c22-8, c29-2, 
L358, PK1 and Apico were performed using the following cycling condition: 4 
min at 94°C followed by 35 cycles of 30 s at 94°C, 1 min at 60°C, 2 min at 72°C 
and a final extension of 10 min at 72°C. Internal PCRs for loci BTUB and GRA6 
were conducted as follows: 4 min at 94°C followed by 35 cycles of 1 min at 94°C, 
1 min at 55°C, 1 min at 72°C and a final extension of 5 min at 72°C. Internal PCR 
for locus SAG3 was done as follows: 4 min at 94°C followed by 35 cycles of 1 
min at 94°C, 1 min at 65°C, 1 min at 72°C and a final extension of 5 min at 72°C. 
PCR-amplification of additional chromosomal marker regions was carried 
out using standard protocols as described [TGMD]. Loci of genetic marker re-
gions were amplified by PCR using the primers listed in Table 10. For all PCR 
reactions, HPLC-purified primers were used at a final concentration of 0.5 mM, 
dNTPs at a final concentration of 250 µM each (Stratec Molecular, Germany) and 
Taq Polymerase (Stratec Molecular, Germany) at a final concentration of 1 U/25 
µl with the buffer system supplied with the enzyme (Stratec Molecular, Germany). 
The PCRs were performed using the following cycling condition: 5 min at 94°C 
followed by 39 cycles of 1 min at 94°C, 1 min at 55°C, 1 min at 72°C and a final 








Table 10: PCR primers and restriction enzymes (RE) used for nested multilocus PCR-RFLP.  
ext: external; int: internal; F: forward; R: reverse; min: minutes; h: hour; *digest conditions: re-
striction enzymes, buffer, temperature and time 
Locus Primers Sequence (5’-3’) Digest* Reference 











TaqI + HinfI, 
TaqI, 37°C for  
30 min, 65°C for 
30 min 
[Khan et al., 











37°C for 1 h 
[Grigg and 
Boothroyd, 











TaqI, 37°C for 
1 h, 65°C for 1 h 
[Khan et al., 










Tru1I, buffer R, 
65°C for 1 h 
[Fazaeli et 
al., 2000; Su 










Tango, 37°C for 
30 min 











go, 37°C for 1 h, 
65°C for 1 h 











buffer R, 37°C 
for 1 h 











Tango, 37°C for 
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Tango, 37°C for 
1 h 
[Su et al., 
2006] 






buffer R, 37°C 
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HinfI, buffer R, 













BseRI, buffer R, 






MboI, buffer R, 
37°C for 1 h 
[TGMD] 
 
2.2.4 Analysis using virulence markers and DNA sequencing 
Virulence marker CS3 was analysed by using the standard PCR protocol as 
described for genotyping newSAG2 [Pena et al., 2008] but using the primers 
listed in Table 11.  
To detect the absence or presence of UPS-ROP18 [Khan et al., 2009], the 
two primer pairs listed in Table 11 were used in a conventional PCR with the fol-
lowing cycling conditions: 5 min at 95°C followed by 35 cycles of 30 s at 4°C, 30 




For all PCR reactions HPLC-purified primers were used at a final concentration of 
0.5 mM, dNTPs at a final concentration of 250 µM each (Stratec Molecular, Ger-
many) and Taq Polymerase (Stratec Molecular, Germany) at a final concentration 
of 1 U/25 µl with the buffer system supplied with the enzyme (Stratec Molecular, 
Germany).  
UPS-ROP18 was sequenced using the primers listed in Table 11. Primers to 
sequence UPS-ROP18 were designed using DNA sequences for type I (GT1), type 
II (ME49) and type III (VEG) deposited at toxodb.org. The full length sequence of 
type III ROP18 including the UPS was recovered by using the BLAST function 
and identified as TGVEG_chrVIIa1490900-1500951. Primers were designed us-
ing Lasergene 8.0 software. All primers were tested in a conventional PCR first. 
To sequence the UPS-ROP18 region, sequencing primers were generated for am-
plifying products of approximately 600 bp in length with at least 100 bp overlap 
between the respective sequences. Amplification of the UPS-ROP18 of type I/II T. 
gondii clones was performed using primers UPS-ROP18-1F and UPS-ROP18-4F. 
UPS-ROP18 type III T. gondii clones were sequenced after conventional PCR 
with unlabelled primers UPS-ROP18-1F/UPS-ROP18-2R and UPS-ROP18-
3F/UPS-ROP18-4F. Direct sequencing of amplification products was carried out 
using a sequencing kit (Thermo Sequenase DYEnamic Direct Cycle, GE 
Healthcare, Germany) and the primers listed in Table 11. All forward primers 
were labelled with DY782, reverse primers with DY682 at their 5’end. Each DNA 
sample was sequenced in a LI-COR DNA Sequencer 4200 (MWG Biotech, Ger-
many). Consensus sequences were assembled using the Lasergene 8.0 software 
(DNA Star Inc., Madison, USA) and compared with sequences of T. gondii type I 









Table 11: PCR primers and restriction enzymes (RE) used for PCR-RFLP, conventional PCR and 
UPS-ROP18 sequencing.  
ext: external; int: internal; F: forward; R: reverse; min: minutes; h: hour; *digest conditions: re-
striction enzymes, buffer, temperature and time 










buffer G, 37°C 
for 1 h 














































2.3 Parasitological methods 
2.3.1 Faecal sample collection 
Faecal samples from cats and dogs were provided by two veterinary labora-
tories: VetMed Labor GmbH (Ludwigsburg) and Veterinärmedizinisches Labor 
Freiburg (Freiburg). Both laboratories received feline and canine faecal samples 
collected by cat owners and veterinarians. Canine faecal samples from another 
project regarding N. caninum in dogs were also analysed for the presence of T. 
gondii.  Samples were examined by a conventional floatation method using 262 




transferred onto a slide and examined by light microscopy using a magnification 
of at least 200x. When oocysts with a diameter of about 9–14 µm were detected, 
the remaining sample was posted to the Friedrich-Loeffler-Institut (FLI), Wuster-
hausen, Germany.  
2.3.2 Oocyst isolation from faeces 
Samples received at the FLI were examined by a combined sedimentation 
and floatation procedure as previously described [Schares et al., 2005]. Routinely, 
100 ml beakers and small sieves (diameter 7.5 cm diameter) were used for sedi-
mentation. Faecal matter was mixed and put through a strainer into the conical 
beaker. Water was added up to the 100 ml mark and stirred to ensure that no mate-
rial stack to the edges and wall of the beaker. Material was left to sediment for 1 
hour (day 1). After sedimentation, the supernatant was poured into another conical 
beaker and left for sedimentation overnight (day 2). Concentrated sucrose solution 
was added to the sediment and transferred into a 50 ml tube followed by a centrif-
ugation step of 10 min at 1,600 x g. To identify oocysts by light microscopy, a 
sample of the floating oocysts was taken and transferred onto a microscope slide. 
The oocyst sample was analysed and photographed using a 400x magnification for 
reference and identification purposes. Diameters of oocysts were measured. After 
centrifugation, 2 ml tap water was pipetted on top of the floatation fluid. The wa-
ter phase was then carefully stirred with the use of a pipette tip. Between 3 and 4 
ml of the upper phase containing oocysts were recovered. Resulting material was 
then washed 3 times in 50 ml tap water at 1,600 x g, 10 min without brake. The 
number of oocysts was estimated by microscopic examination of 10 µl using a 
Neubauer chamber and an aliquot of 104 oocysts was used for DNA isolation. If 
the concentration of oocysts was too low to count them in the Neubauer chamber, 
a 2.5 ml aliquot was used for DNA isolation. If 2.5 ml of oocyst suspension failed 
to yield sufficient DNA to amplify the target by PCR, a 5 ml aliquot was used for 




croscopy. Oocysts were allowed to sporulate by incubation at room temperature 
for 72 or 96 h under aerated conditions and then stored in K2Cr2O7 at a final con-
centration of 1–2% (w/v) at 4–8°C until use. 
2.3.3 Isolation of sporozoites from T. gondii oocysts (excystation) 
A minimum of 106 T. gondii oocysts stored in 1–2% K2Cr2O7 were washed 
four times in a 15 ml falcon tube by centrifugation (1,100 x g, 7 min, without 
brake) in 15 ml PBS. The pellet, containing oocysts and remaining contaminants, 
was incubated in 2 ml 4% NaOCl (15 min at 37°C), then filled up to 12 ml with 
double-distilled H2O and centrifuged (1,100 x g, 7 min, without brake). The pellet 
was resuspended and washed three times with sterile Dulbecco’s Minimum Ea-
gle’s Medium (DMEM) at 1,100 x g, 7 min, without brake. The supernatant was 
removed and 5 ml sterile DMEM added to the pellet. The ultrasound rod was 
washed three times with sterile DMEM before use. The suspension was treated 
with ultrasound four times for 30 s (50% active cycle, output level 3) with a 30 s 
break between cycles. The samples were kept on ice during the entire sonication 
procedure. The resulting solution was centrifuged at 1,100 x g for 7 min, without 
brake. The supernatant was discarded and the pellet resuspended in 2 ml 0.75% 
tauchocholat for 2 hrs at 37°C. The sample was washed with sterile DMEM and 
centrifuged at 1,100 x g for 7 min, without brake. The sample was checked for 
free sporozoites under the microscope (400x magnification). When free sporozo-
ites were observed, the solution was added to a VERO cell monolayer. The cell 
culture was checked three times daily for plaque formation. 
2.3.4 Isolation of tachyzoites from T. gondii by bioassay 
Infected GKO and BALB/c mice were observed daily for any clinical signs. 
When the first clinical signs were observed, the infected mice were anaesthetised 
by injection of 0.1 ml of a xylazin/ketamin hydrochloride mixture [Schares et al., 




skinned and peritoneal fluid was recovered by washing the peritoneal cavity with 
1 ml sterile DMEM. The recovered fluid was inspected for the presence of T. 
gondii tachyzoites under a microscope. If no tachyzoites were detected, half of the 
heart and brain (approximately 0.05 g and 0.2 g, respectively) were homogenised 
by pestle and mortar and 1 ml sterile RMPI medium was added. The recovered 
parasite suspension or the homogenized tissues (approximately 1 ml) were added 
to VERO cells. After 4 h cell culture medium was replaced with fresh medium. 
Cell cultures were checked for parasite growth daily. 
2.3.5 In-vitro parasite maintenance 
All T. gondii isolates derived from bioassay and T. gondii reference strains 
(RH, ME49 and NED) were maintained in VERO cell monolayers using Dulbec-
co’s MEM with 2% foetal calf serum and 1% antibiotic solution (10,000 IU Peni-
cillin and 10,000 µg Streptomycin/ml solution) at 37°C and 5% CO2.  
2.3.6 Tachyzoite isolation from cell culture for DNA or protein extraction 
At least one day prior to harvesting cells, FCS-containing medium was re-
placed with FCS-free medium. Any remaining cells containing tachyzoites were 
scraped off using a cell scraper. All material was transferred to a 50 ml falcon tube 
and centrifuged for 10 minutes at 2,500 rpm, 4°C without brake. The resulting 
suspension was pressed through a syringe with a 27G needle and further filtered 
using a 5 µm sterile syringe filter (Sartorius, Germany). The total parasite number 
was calculated using the improved Neubauer chamber method. 
2.3.7 Tachyzoite isolation from cell culture for in-vivo infections 
To isolate parasites for in-vivo use, several VERO cell cultures were infect-
ed simultaneously to ensure that enough parasites could be harvested. Cells were 




harvesting, cells were kept in FCS-free medium. Parasites were harvested by 
transferring free tachyzoites into 50 ml falcon tubes. Tachyzoites were washed 
three times for 10 minutes in sterile PBS at 2,500 rpm, 4°C, without brakes. The 
concentration of live parasite was determined using the improved Neubauer 
chamber method in the presence of Trypan-Blue. The required number of live 
tachyzoites was prepared in DMEM medium and kept on ice until use.  
2.3.8 Cloning of T. gondii by limiting dilution 
Limiting dilutions were carried out in 96-well-plates (Greiner, Germany). 
VERO cells were seeded at 106 cells per well. Resulting monolayers were infected 
by adding 200 µl medium containing a calculated number of 0.1–0.5 parasites per 
well. When the first single plaque was observed, parasites were transferred into 25 
cm2 tissue culture flasks (Greiner, Germany) and clonally propagated in VERO 
cells as previously outlined. 
2.4 Immunoblot analysis 
TgSAG1 was obtained by immune affinity chromatography using the 
mouse monoclonal antibody (mAb) IgG2a P30/3 (ISL, UK) as described by 
[Maksimov et al., 2011]. The purity of TgSAG1 was checked by sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), Western blotting and 
India ink staining [Schares et al., 2000]. The amount of recovered TgSAG1 was 
determined relative to a standard of bovine serum albumin by silver staining 
[Heukeshoven and Dernick, 1988]. Affinity purification of TgSAG1 resulted in an 
antigen preparation that was free off detectable contaminating components 
[Hosseininejad et al., 2009]. 
To detect antibody reactions against the immunodominant surface antigen 
TgSAG1 of T. gondii, previously described protocols were employed (Maksimov 




[Maksimov et al., 2011]. PVDF membranes with transferred TgSAG1 were cut 
into strips and blocked using PBS-TG (PBS-T, 2% (v/v) fish gelatine liquid 
(Serva, Germany) for 15 min. PBS-TG was removed and each strip was incubated 
with body or tissue fluid diluted 1:2 in PBS-TG for 1 h. Strips were washed five 
times using PBS-T followed by incubation with AffiniPure Rabbit Anti-Dog 
IgG+IgM (H+L) (Jackson ImmunoResearch, USA) diluted 1:250 in PBS-T for 1 
h. Strips were then washed three times using PBS-T and two times using PBS and 
incubated with a substrate solution (40 μl H2O2 (30% (v/v)) and 30 mg 4-chloro-
1-naphthol (Sigma–Aldrich, USA) in 40 ml PBS, 20% (v/v) methanol) for 20 min. 
Test results were regarded as positive if the TgSAG1 band at 30 kDa was detect-
ed. 
 
2.5 Statistical methods 
2.5.1 Analysis of feline faecal samples June 2007–December 2008 
The 95% confidence intervals (CI) for prevalence data were calculated by 
approximation assuming a binomial distribution and an infinite cat population. 
Differences among the quarters of a year regarding the proportion of T. gondii-
positive samples received by VetMed Labor GmbH in the different seasons were 
examined with the Fisher’s Exact Test. To determine whether positive samples 
were overrepresented relative to negative samples in a particular age group, data 
were analysed by the Fisher’s Exact Test. The spatial analysis of sample data was 
based on postcodes and samples without location data were excluded from the 
analysis. Prior to analysis, the data sets based on the postcode areas, were attribut-
ed to the administrative level of districts (‘Landkreise’ and ‘kreisfreie Städte’) for 
Germany (Bundesamt für Kartographie und Geodäsie, Frankfurt am Main, Ger-
many). Population density data were available at the district level for the year 
2007. Geographic analyses were performed using ArcGIS software version 9.3 




pare the population densities of districts where samples from T. gondii-positive 
and -negative cats had been submitted from (Statistica 7.1, Stat Soft Inc., Tulsa, 
USA). P values lower than 0.05 were considered statistically significant. 
2.5.2 Analysis of virulence data 
Weight data for each day and animal were recorded in Microsoft Excel 
spread sheets. Maximum weight loss was calculated using the Min() function of 
Excel and subsequently transferred to GraphPad Prism 4 Software (GraphPad 
Software, San Diego California USA) for further analysis. Using the statistical 
package included in Prism 4, each infection group at each dose was compared to 
the control animals using the Mann-Whitney U test. P values lower than 0.05 were 















3.1 Isolation and characterisation of animal samples 
3.1.1 Isolation of T. gondii oocysts from faecal samples 
Between June 2007 and December 2010, 258 feline and canine faecal sam-
ples from Germany containing T. gondii-like oocysts were received for further 
analysis. The two collaborating veterinary laboratories, VetMed Labor GmbH 
(Ludwigsburg) and Tierärztliches Labor Freiburg (Freiburg), submitted only fae-
cal samples in which they had detected T. gondii-like oocysts with an average 
diameter of 9–14 µm. A total of 143 feline faecal samples and 115 canine faecal 
samples from Germany were analysed. Oocysts were isolated by sedimentation/ 
floatation. DNA was isolated and species-specific PCRs for T. gondii, H. ham-
mondi, H. heydorni and N. caninum carried out. An example of a diagnostic anal-
ysis is shown in Figure 3.  
In 74/143 (51.75%) feline faecal samples and 5/115 (6.09%) of the canine 
faecal samples T. gondii oocysts were present as detected by sedimenta-
tion/flotation and subsequent specific PCR (Figure 4). 47/143 (32.87%) of the 
feline faecal samples and 5/115 (4.35%) of the canine faecal samples contained 
oocysts of H. hammondi (Figure 5). More than half of all analysed canine faecal 
samples contained oocysts of H. heydorni (58/115; 50.43%), whereas 10/115 
(8.70%) of the canine faecal samples contained oocysts of N. caninum. None of 
the feline faecal samples contained H. heydorni or N. caninum oocysts. In two 
canine faecal samples (2/115; 1.74%), DNA of H. heydorni and of N. caninum 
was detected by specific PCR. It was concluded that a mixed infection had oc-
curred in both cases. Also, 6/143 (4.20%) of the feline faecal samples and 13/115 
(11.30%) of the canine faecal samples were PCR-positive for coccidian-specific 




These cats and dogs were possibly infected with a coccidian parasite different 
from the tested species. They were therefore further analysed for the presence of 
Besnoitia besnoiti DNA. None of the coccidian positive faecal samples from 
Germany tested PCR-positive for B. besnoiti by PCR. A small number of feline 
faecal sample (15/143; 10.49%) and of canine faecal samples (19/115; 16.52%) 
containing at least one oocysts, as analysed by light microscopy after sedimenta-
tion/floatation at the veterinary laboratories, tested PCR-negative for coccidian 
specific DNA at the FLI. The parasites in these samples remained unidentified. In 
cases where the PCR-specific signals for T. gondii were weak, the bioassay was 
carried out to isolate T. gondii. A total of 29 feline and 35 canine faecal samples 
from outside Germany were also analysed. Two of 35 (5.71%) canine faecal sam-
















































































































































































































































































































































































































































































3.1.2 Bioassay of T. gondii oocysts in GKO mice 
The bioassay for T. gondii in GKO mice was carried out with oocyst sam-
ples that tested weakly T. gondii PCR-positive or contained little oocyst DNA. 
This way enough DNA might be generated by subsequent cell culture as high 
amounts of DNA are required for genotyping by PCR-RFLP. Furthermore, the 
objective was also to generate as many field isolates of T. gondii from Germany as 
possible for future reference and scientific research with regards to phylogeny and 
virulence studies. In cases where sporulated T. gondii (Figure 6) were observed 
and especially in cases where the PCR-specific bands for T. gondii were weak, 
bioassay in mice was carried out. Oocyst samples, in which T. gondii was detected 
by PCR, were identified and designated accordingly. In total, T. gondii tachyzoites 
could be isolated and further propagated in VERO cell culture from one T. gondii 
oocyst sample of canine origin (Table 12) and 33 T. gondii oocyst samples of fe-
line origin (Table 13). One sample (TG-GER045) was used to liberate sporozoites 
from the oocysts and to isolate T. gondii tachyzoites in VERO cells without an 
initial passage through GKO mice. This was only possible due to the high number 
of sporulated oocysts (> 106 oocysts/ml) contained in the sample. 
GKO mice inoculated with 103 sporulated oocysts usually showed clinical 
signs of infection, such as immobility, raised fur hair, hump-back and shaking 
head at 10 d.p.i. and were sacrificed when these signs were observed. Notable 
exceptions to his rules were infections with oocysts of sample TG-GER054 and 
TG-GER63. Only 102 oocysts were used to bioassay TG-GER054 thus explaining 
the late signs of disease (18 d.p.i.). As will be discussed later, TG-GER63 con-
tained many highly mouse-virulent T. gondii clones that may have accelerated 
disease progression. Isolate TG-GER63 was also isolated from BALB/c mice 
(B136/1-5) following the isolation of T. gondii tachyzoites from GKO mouse 
K119/1. This was necessary to identify various T. gondii clones with differences in 




signs of disease in BALB/c mice infected with T. gondii isolated from GKO 
mouse K119/1 were noted 6 days later than in GKO mice at 16 d.p.i.. Bioassay of 
T. gondii from mice failed for eight samples (Tg-dgGER08, TG-GER34, 46, 51, 
55, 62, 85, 87). In these cases it seemed that the visible oocysts were either not yet 
fully sporulated or not infectious any longer. 
 
Figure 6: Microscopic examination of a feline faecal sample.  




Table 12:  Bioassay of T. gondii oocysts from canine faecal samples in mice.  





TG-dgGER05 Dog Oocysts K106 11 GKO 




Table 13: Bioassay of T. gondii oocysts from feline faecal samples in mice.  





TG-GER24 Cat Oocyst K105 10 GKO-mouse 
TG-GER28 Cat Oocyst K66 10 GKO-mouse 
TG-GER30 Cat Oocyst K102 13 GKO-mouse 
TG-GER32 Cat Oocyst K68 10 GKO-mouse 
TG-GER33 Cat Oocyst K67 10 GKO-mouse 
TG-GER34 Cat Oocyst K103 - GKO-mouse 
TG-GER35 Cat Oocyst K69 10 GKO-mouse 
TG-GER36 Cat Oocyst K70 10 GKO-mouse 
TG-GER36 Cat Oocyst K72 10 GKO-mouse 
TG-GER37 Cat Oocyst K73 10 GKO-mouse 
TG-GER38 Cat Oocyst K76 10 GKO-mouse 
TG-GER39 Cat Oocyst K78 16 GKO-mouse 
TG-GER40 Cat Oocyst K79 11 GKO-mouse 
TG-GER41 Cat Oocyst K80 10 GKO-mouse 
TG-GER42 Cat Oocyst K84 12 GKO-mouse 
TG-GER43 Cat Oocyst K83 9 GKO-mouse 
TG-GER45 Cat Sporozoite - - VERO cell 
TG-GER46 Cat Oocyst K101 - GKO-mouse 
TG-GER49 Cat Oocyst K104 10 GKO-mouse 
TG-GER50 Cat Oocyst K107 9 GKO-mouse 
TG-GER51 Cat Oocyst K81 - GKO-mouse 
TG-GER54 Cat Oocyst K114 18 GKO-mouse 
TG-GER55 Cat Oocyst K115 - GKO-mouse 
TG-GER61 Cat Oocyst K126 13 GKO-mouse 
TG-GER62 Cat Oocyst K127 - GKO-mouse 
TG-GER63 Cat Oocyst K119/1 8 GKO-mouse 
TG-GER63 Cat Oocyst K119/1 8 GKO-mouse 
TG-GER63 Cat Tachyzoite B136/1 20 BALB/c-mouse 
TG-GER63 Cat Tachyzoite B136/2 22 BALB/c-mouse 
TG-GER63 Cat Tachyzoite B136/3 23 BALB/c-mouse 
TG-GER63 Cat Tachyzoite B136/4 21 BALB/c-mouse 
TG-GER63 Cat Tachyzoite B136/5 21 BALB/c-mouse 
TG-GER63 Cat Oocyst K128/1 8 GKO-mouse 
TG-GER63 Cat Oocyst K128/2 8 GKO-mouse 
TG-GER63 Cat Oocyst K128/3 8 GKO-mouse 
TG-GER63 Cat Oocyst K128/4 8 GKO-mouse 
TG-GER78 Cat Oocyst K159 12 GKO-mouse 
TG-GER79 Cat Oocyst K160 10 GKO-mouse 
TG-GER85 Cat Oocyst K163 - GKO-mouse 




3.1.3 Seasonality, age and spatial distribution of cats shedding T. gondii 
oocysts 
Statistical analysis of the age of oocyst-shedding cats and the seasonality of 
oocyst-shedding was only carried out for the period between 2007 and 2008 and 
for feline faecal samples submitted by VetMed Labor GmbH since for that period 
and from this particular laboratory all data sets were obtained for complete analy-
sis. For each month, the total number of feline faecal samples received by VetMed 
Labor GmbH was inquired and correlated to the number of T. gondii positive fae-
cal samples as analysed by PCR. The numbers of T. gondii-positive and -negative 
faecal samples were analysed by the Fisher’s Exact Test for each month and 
summarised for each quarter (QT). 
A total of 18,259 feline faecal samples were received for diagnosis at Vet-
Med Labor GmbH. During the whole period, 45/18,259 (0.25%) cats shed T. 
gondii oocysts, whereas 33/18,259 (0.18%) cats shed H. hammondi oocysts. 
Among all the samples received at VetMed Labor GmbH between 2007 and 2008, 
the proportion of T. gondii-positive samples (n = 45; 0.25%) differed depending 
on the submission month and the quarter of the year (Table 14 and Table 15). In 
the first (January–March), second (April–June), third (July–September) and fourth 
quarter (October–December), 0.16% (4/2,549), 0.03% (1/2,953), 0.37% 
(21/5,734) or 0.27% (19/7,023) of the samples tested positive for T. gondii (Table 
15). To compare T. gondii-positive and -negative feline faecal samples quarter 
wise, Fisher’s Exact Test was applied. The differences were only statistically sig-
nificant (Fisher’s Exact Test; P > 0.05) when the 2nd and the 3rd quarter (P = 
0.002) and the 2nd and 4th quarter (P = 0.01) were compared (Table 16). When 
combining several months, statistically significant differences were observed be-
tween the 2nd quarter and quarters 1+3+4 as well as between the 3rd quarter and 
quarters 1+2+4. Following this analysis, the year was divided into two halves 
ranging from January-June and from July-December. T. gondii positive and nega-




When the 1st half of the year (January–June) was compared to the 2nd half (July– 
December), a significantly higher proportion of samples tested positive for T. 
gondii oocysts in the 2nd half of the year (P = 0.005).  
 
Table 14: Total number of samples analysed by VetMed Labor GmbH and number of samples 
analysed positive for T. gondii or H. hammondi per month.  
Total number of samples and number of samples tested. 
Month Samples  T. gondii positive (%) 
H. hammondi positive 
(%) 
January 1,007 1 (0.10) 4 (0.40) 
February 829 1 (0.12) 0 (0.00) 
March 713 2 (0.28) 1 (0.14) 
April 794 0 (0.00) 0 (0.00) 
May 688 0 (0.00) 0 (0.00) 
June 1,471 1 (0.07) 1 (0.07) 
July 1,791 8 (0.45) 1 (0.06) 
August 1,841 10 (0.54) 3 (0.16) 
September 2,102 3 (0.14) 1 (0.05) 
October 2,541 7 (0.28) 8 (0.31) 
November 2,488 8 (0.32) 9 (0.36) 
December 1,994 4 (0.20) 5 (0.25) 







Table 15: Total number of samples analysed by VetMed Labor GmbH and number of 
samples tested positive for T. gondii or H. hammondi per quarter of the year.  
Total number of samples and number of samples tested.  
Quarter (QT), 
(period) 





(January–March) 2,549 4 (0.16) 5 (0.20) 
QT2 
(April–June) 2,953 1 (0.03) 1 (0.03) 
QT3 
(July–September) 5,734 21 (0.37) 5 (0.09) 
QT4 
(October–December) 7,023 19 (0.27) 22 (0.31) 















Table 16: Statistical analysis (Fisher’s Exact Test) of T. gondii oocyst shedding for different quar-
ters of the year.  
QT=Quarter, Statistically significant differences (P < 0.05, Fisher’s Exact test) are indicated by 
bold letters. 
Comparison T. gondii positive; T. gondii negative [n] 
T. gondii positive; 
T. gondii negative [n] 
Significance 
[P =] 
QT1 vs QT2 4;   2,545 1;   2,952 0.1893 
QT1 vs QT3 4;   2,545 21;   5,713 0.1304 
QT1 vs QT4 4;   2,545 19;   7,004 0.4780 
QT2 vs QT3 1;   2,952 21;   5,713 0.0024 
QT2 vs QT4 1;   2,952 19;   7,004 0.0128 
QT3 vs QT4 21;   5,713 19;   7,004 0.3443 
QT1 vs QT2+3+4 4;   2,545 41; 15,669 0.3959 
QT2 vs QT1+3+4 1;   2,952 44; 15,262 0.0070 
QT3 vs QT1+2+4 21;   5,713 24; 12,501 0.0355 
QT4 vs QT1+2+3 19;   7,004 26; 11,210 0.6464 






Another aim of the study was to determine if T. gondii oocyst shedding 
could be correlated to a certain age or age group. The age ranges of the cats from 
which T. gondii-positive samples were obtained were therefore compared accord-
ingly. Three categories of age ranges were formed: group 1) one year and younger, 
group 2) 1–7 years and group 3) older than seven years. Complete data sets were 
available for 34 cats. Among these animals, 18/34 (52.94%) positive cats were up 
to one year old. Sixteen animals (16/34; 47.06%) were older than one year of age. 
6/34 (17.65%) of T. gondii-positive cats were between one and seven years old. 
Only five T. gondii-positive cats (5/34; 14.71%) were below the age of six 
months. Ten (10/34; 29.41%) cats were older than seven years and the oldest cat 
shown to shed T. gondii oocysts was 18 years old. The results are summarised in 
Figure 7. Samples from ten T. gondii-negative cats were randomly selected per 
month (i.e. a total number of 190 cats) and included into the statistical analysis. 
These samples allowed comparison of T. gondii-positive cats with T. gondii-
negative cats with regards to (i) the age when they shed oocysts and (ii) the geo-
graphical locations where the cat samples had been submitted from. The age dis-
tribution among the T. gondii-positive cats was similar to that of the T. gondii-
negative cats. In the negative sample 81/190 (42.63%) of the cats were up to one 
year old, 47/190 (24.74%) cats were 1–7 years old and 62/190 (32.63%) cats were 
older than seven years old. No statistically significant difference regarding the 
proportion of cats between T. gondii-positive and T. gondii-negative animals was 
observed (Fisher’s Exact test; P > 0.05). 
It was assumed that cats kept in rural areas were more susceptible to infec-
tion with T. gondii and thus more likely to shed oocysts. Cats in those areas were 
also more likely to roam freely and had thus easier access to infected intermediate 
host species of T. gondii, such as birds and rodents. It was also more likely that 
cats in such areas were fed less processed and tinned cat food thus increasing the 
likelihood of getting infected and to shed oocysts. It was thus hypothesised that 




oocysts than cats from rural areas with a lower population density. To test this 
hypothesis, the possible influence of human population density on the shedding of 
T. gondii oocysts of cats was also analysed. If the postal code of the place where 
the cat sample had been submitted from was available, the respective data set was 
analysed by comparing the geographical origin of the T. gondii-negative samples 
with that of the T. gondii-positive samples with regard to human population densi-
ty at the district level. T. gondii-negative samples came from districts with a mean 
human population density of 710.50 (CI: 643.10–777.90) persons per square kil-
ometre (km2), whereas T. gondii-positive samples came from districts with a mean 
population density of 815.80 (CI: 666.20–965.20) persons per km2. The differ-
ences in the population density were not statistically significant between the dis-
tricts where negative and positive samples had been submitted from (P > 0.05; 
Mann-Whitney U Test). Only three out of 44 (6.82%) T. gondii-positive samples 
came from districts with a population density of less than 100 persons per km2. 
Twelve positive samples (27.27%) originated from districts with a population den-
sity of 100–500 persons per km2, whereas 29 positive samples (65.91%) came 





























































































































Figure 8: Map of Germany showing where T. gondii-positive and -negative samples (June 2007-
December 2008) originated from.  
Red dots indicate T. gondii-negative sample; green dots represent T. gondii-positive sample. The 
size of the dots corresponds to different sample size. Population density (inhabitants/km2) is shown 




3.1.4 Genotyping of T. gondii isolated from animal samples 
Genotyping was performed with T. gondii-DNA isolated from oocysts or 
tachyzoites (if cultivation in VERO cells after bioassay in mice had been success-
ful) utilising eight unlinked, independent chromosomal marker regions      
(newSAG2, SAG3, BTUB, GRA6, c22-8, c29-2, L358 and PK1) and one extra-
chromosomal marker region (Apico). An example of a PCR-RFLP analysis using 
the nine markers is shown in Figure 9. 
A total of 104 T. gondii-positive isolates from Germany were examined. 
Twenty-two isolates (collected between October 2004 and November 2006) had 
been only partially characterised in a previous study [Schares et al., 2008b]. All 
these isolates were now further analysed for the loci c22-8, c29-2, L358, PK1 and 
Apico [Su et al., 2006]. Oocysts of four isolates which could not be genotyped in 
the previous study because PCR amplification of the marker regions had failed 
were now fully typed by PCR-RFLP. The remaining isolates were analysed and 
genotyped for the first time. The typing results for the feline T. gondii isolates at 
all nine loci are summarised in Table 17. The majority (89/104; 85.58%) of these 
feline T. gondii isolates (collected October 2004–November 2006 and June 2007 – 
December 2010) displayed predominantly type II alleles. Of the 89 samples geno-
typed as type II at all chromosomal loci, 83 possessed the type I allele (83/104; 
79.81%) and six (6/104; 5.77%) displayed the type II allele at the Apico locus 
(Figure 10). One of the 104 isolates, TG-GER13, which could previously not be 
characterised, was shown to be of type III at all loci (1/104; 0.96%). No clonal 
type I isolate was detected. Among the 104 isolates, there were four isolates of 
non-canonical or mixed genotype (4/104; 3.85%). TG-GER02, which had previ-
ously been characterised as type II at loci 5’ and 3’SAG2, BTUB, SAG3 and 
GRA6 only, was now shown to contain alleles of types I and II at loci c29-1 and 
PK1. TG-GER02 was thus identified as a non-canonical, mixed T. gondii isolate. 




loci Apico and BTUB. This isolate was characterised as type I at the Apico locus, 
but as types I or II at the BTUB locus. When PCR-RFLP were conducted for 
BTUB I and BTUB II separately, the isolate revealed the type II allele at the 
BTUB II locus, but type I and II or III alleles at the locus BTUB I. Isolate TG-
GER61 showed a mixed allele pattern only at the Apico locus. Interestingly, iso-
late TG-GER63 showed a mixture of type II and III alleles at some loci. While 
only type II patterns could be observed at the loci SAG3 and BTUB, type III al-
leles were found at GRA6, L358 and Apico loci and a mixture of type II and III 
alleles at the c22-8, c29-2 and PK1 loci. In addition, a mixture of type I or III and 
II alleles was found at the newSAG2 locus in the isolate TG-GER63. Ten isolates 
(10/104; 9.62%) could not be fully genotyped at all nine loci (TG-GER09, 17, 34, 
46, 51, 62, 83, 87, 100 and 104). TG-GER09 could only be genotyped at the loci 
newSAG2, GRA6, c22-8, L358 and Apico. All loci showed alleles of type II. TG-
GER17 had alleles of type II at the loci newSAG2, SAG3, BTUB and GRA6, but 
showed a type I allele at the Apico locus. Isolate TG-GER34 could be genotyped 
at the loci SAG3, GRA6 and Apico and showed type II alleles at these loci. Iso-
lates TG-GER46 and 52 showed alleles of type II at the loci BTUB, c22-8, L358 
and PK1. Additionally, TG-GER51 had a type I allele at the Apico locus. Isolate 
TG-GER62 shared a type I allele at the Apico locus and a type II alleles at the 
newSAG2, SAG3, GRA6 and c22-8 loci. In isolate TG-GER83, a type I allele was 
observed at the Apico locus and a type II allele at the SAG3 locus. The loci c22-8 
and c29-2 of TG-GER87 were of type II but the Apico locus showed a type I al-
lele. Alleles at loci newSAG2, BTUB, c22-8, PK1 of isolate TG-GER100 were of 
type II, but the Apico locus showed a type I allele. No locus could be PCR-
amplified from the TG-GER104 isolate. All results are summarised in Table 17 








Figure 9: PCR-PFLP polymorphism analyses of the T. gondii isolate TG-GER63.  
Nine genetic markers (newSAG2, SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1 and Apico) 
were utilised. All DNA fragments resulting from specific PCR and DNA endonuclease digestions 
were resolved in 3% agarose gels. Marker regions: newSAG2, SAG3, BTUB, GRA6, c22-8, c29-
2, L358, PK1, Apico; M: 100 bp DNA molecular size marker (Invitrogen, Germany); I, III, III: 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.2 Genetically and biological characterisation of isolate TG-GER63 
Interestingly, sample TG-GER63 showed more than one allele at several lo-
ci (Table 17 and Figure 11) and also contained sporulated oocysts. Such unusual 
allele patterns could only appear if at least two genetically different T. gondii oo-
cysts existed in the sample. Since TG-GER63 had been isolated from a single fe-
line faecal sample, it seemed most likely that all oocysts contained in the sample 
originated from a single cat. However, this also meant that the cat must have har-
boured at least two genetically different T. gondii.  
It followed that sexual recombination of T. gondii may have taken place in 
the cat which might have generated not only the parental T. gondii genotypes by 
selfing but also many genetically recombinant or re-assorted T. gondii. Even more 
remarkable is the presence of type III and type II alleles in the oocysts sample, 
since type III was shown to be rare in cats in Germany. Two different scenarios 
may explain such an allele pattern in TG-GER63: (i) there were only type II and 
type III T. gondii in this single faecal sample, but differential PCR amplification 
of different loci revealed the mixed allele patterns found at some but not all loci 
(ii) all observations of a single type-specific allele observed at a single locus (e.g. 
at loci SAG3, BTUB, GRA6, L358 and Apico) were not due to differential PCR 
amplification, but the real genetic situation was reflected in the PCR-RFLP. 
Therefore, all observations of more than one type-specific allele observed at a 
single locus (i.e. at the loci newSAG2, c22-8, c29-2 and PK1) were not the result 
of differential PCR amplification, but the real genetic situation reflecting a mix-
ture of genetically different T. gondii oocysts in the sample. This would lead to the 
conclusion that the sample had consisted of many genetically different non-
canonical types of T. gondii. To test these two hypotheses, the single oocyst sam-





Figure 11: PCR-RFLP polymorphism analyses of the T. gondii isolate TG-GER63.  
Nine genetic markers (newSAG2, SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1 and Apico) 
were utilised. DNA fragments were resolved in 3% agarose gels. M: 100 bp DNA molecular size 
marker (Invitrogen, Germany); 1: Isolate TG-GER63; 2: negative control (water); 3, 4 and 5: ref-






3.2.1 Bioassay of TG-GER63 oocysts and mouse infections 
To identify different individual genotypes in the oocyst field sample TG-
GER63, two GKO-mice were orally infected with 104 sporulated oocysts from 
TG-GER63. Both mice showed first clinical signs at eight d.p.i. and were sacri-
ficed accordingly. T. gondii tachyzoites were isolated from those mice and cul-
tured on VERO cells (K119/1 and K119/2). Genotyping by PCR-RFLP of the two 
isolates revealed a mixture of type II and III alleles at several individual loci (Ta-
ble 18). The pattern was similar but not identical with the one observed in the 
original oocyst isolate TG-GER63 (Table 17). Tachyzoites harvested from the 
K119/1 cell culture were used to infect five BALB/c mice (B136/1, B136/2, 
B136/3, B136/4 and B136/5) which died 20, 22, 23, 21 or 21 d.p.i., respectively. 
T. gondii-infected VERO cell cultures, one from each mouse, were established 
using peritoneal washings. All T. gondii tachyzoites isolated from infected GKO 





































































































































































































































































































































































































































































































































































3.2.2 Cloning of T. gondii isolates 
In order to separate the components of the mixed T. gondii isolate from each 
VERO cell culture, limiting dilutions were carried out. After each round, the gen-
erated isolates were genotyped. If the isolate still resembled a mixed T. gondii 
culture, subcloning by limiting dilution was carried out. Thus, several rounds of 
limiting dilution resulted in the isolation of 45 distinct T. gondii clones from 
mixed T. gondii VERO cell cultures. A flow diagram illustrating this process con-
taining all clones generated by this method is shown in Figure 12. Most clones 
displayed a combination of type II and III alleles at several different loci. Clones 
displaying an identical allele combinations over all examined loci were thus 
grouped accordingly (Table 19). In total, five genotypically different T. gondii 
clone groups were identified, based on their PCR-RFLP allele pattern. T. gondii 
clones in four groups showed a non-canonical allele pattern that have never been 
described in any intermediate or definitive host species before (groups 2–5). 
Group 1 contained sixteen clones displaying type III alleles at all loci. All twenty-
two clones of group 2 showed alleles of type III at all loci except for a type II al-
lele at PK1 (Chr. VI). Clones within group 3 displayed type II alleles at the BTUB 
(Chr. IX) and c29-2 (Chr. III) loci with all remaining loci shared type III alleles. 
All clones in group 4 displayed type III alleles except for the type II allele at 
newSAG2 (Chr. VIII), c22-8 (Chr. Ib), L358 (Chr. V) and PK1. Group 5 contained 
one clone which was almost identical with members of group 4 except for a type I 
allele at the Apico locus.  
While type II alleles were initially observed at the SAG3 locus (Chr. XII) 
in cell cultures infected with T. gondii of K119/1 and K119/2, none of the subse-
quently isolated clones displayed a type II allele at that locus. Mixed cell cultures 
isolated from K119/1 always showed a mixture of type II and III alleles at the 
GRA6 locus (Chr. X), but no type II allele was observed at this particular locus in 





Figure 12: Flow diagram of T. gondii clones generated from oocyst isolate TG-GER63 by limited 
dilution.  
Bold letters indicate bioassay (B: BALB/c mouse; K: GKO mouse). White shading indicates iso-
lates with a mixed allele pattern at at least one locus. Coloured shadings indicate clones with a 
single allele at a given locus. T. gondii clones shaded with the same colour had the same PCR-

































































































































































































































































































































































































































































































3.2.3 Virulence of isolated T. gondii clones 
To determine the virulence of the clones isolated from TG-GER63, up to 
two clones from each clone group were randomly chosen to determine their in-
vivo virulence in BALB/c mice using different tachyzoite doses of each clone as 
indicated in Table 20. All mice used in these experiments were tested for serocon-
version by immunoblot analysis upon death or at the end of the experiment to con-
firm infection (30 d.p.i.). All mice inoculated with T. gondii seroconverted except 
for mice that died before 10 d.p.i. and three mice inoculated with only 10 para-
sites.  
Representatives of clone groups 1 and 3 were of low virulence in mice. In-
fecting mice with 106 tachyzoites i.p. did not result in death in many mice. Repre-
sentatives of clone group 2 showed an intermediate (LD50 > 102–104 tachyzoites) 
or high (LD50 > 10–100 tachyzoites) virulence phenotype in mice. All representa-
tives of clone groups 4 and 5 were highly virulent (LD50 < 100 tachyzoites) in 
mice. Survival data for all clones at each dose are shown in Figure 13 and Figure 
14. Mice infected with 106 T. gondii from groups 4 and 5 died within 14 days of 
infection. In contrast, animals infected with low-virulent clones survived the chal-
lenge with 106 T. gondii parasites. Interestingly, challenge with T. gondii contain-
ing a mixed population of T. gondii clones (K119/1 and K119/2) killed mice at 27 
and 30 d.p.i. (Figure 13A). Survival data of infection with 104 T. gondii varied 
greatly between clones. The time of death did not seem to be correlated with the 
genotype of the parasite. Although the T. gondii clone with the highest overall 
virulence (B136/1 B6-H6) killed mice earlier at this dose, T. gondii clones of 
group 2 (intermediate and highly virulent T. gondii clones K119/ 2 A7 and B136/2 
C12) showed higher virulence than the highly virulent clones of  B136/5 G12 and 
B136/1 A3-F5 (Figure 13B). The results of the high parasite number challenge 
were confirmed when only 100 parasites were used. Again, T. gondii clones 
B136/5 G12 and B136/1 A3-F5 showed the lowest virulence considering time of 




B136/2 C12 and B136/1 B6-H6 were the most virulent clones at this dose. Inter-
estingly, both highly virulent T. gondii clones had different allele patterns (Figure 
14A). At the low-dose challenge, T. gondii clone B136/1 B6-H6 was the most 
virulent clone followed by T. gondii clone B136/1 A3-F5. Both clones had a very 
similar allele pattern with only the Apico locus being different. Again, T. gondii 
clones B136/5 G12 and B136/2 C12 were the least virulent ones among the high-
































































































































































































































































































































































































































































































Figure 13: Survival of BALB/c mice infected with 106 and 104 genetically different T. gondii 
clones.  
Five BALB/c mice per T. gondii clone were each infected with (A) 106 tachyzoites i.p. or (B) 104 
tachyzoites i.p. of different T. gondii clones. T. gondii clones are indicated each by a different col-
oured line. T. gondii clones that did not show any virulence after infection with the higher dose 





Figure 14: Survival of BALB/c mice infected with 100 and 10 genetically different T. gondii 
clones.  
Five BALB/c mice per T. gondii clone were each infected with (A) 100 tachyzoites i.p. or (B) 10 
tachyzoites i.p. of different T. gondii clones. T. gondii clones are indicated each by a different col-
oured line. T. gondii clones that did not show any virulence after infection with the higher dose 





Figure 15: Maximum weight loss of BALB/c mice upon experimental infection with genetically 
different T. gondii clones.  
Five animals per group were infected with 106, 104, 102 or 10 T. gondii tachyzoites i.p. each. Data 
shown are maximum weight loss (in per cent), virulence markers: UPS-ROP18 [Khan et al., 2009] 
and CS3 [Pena et al., 2008] and genetic marker PK1 [Su et al., 2006]. 
 
All mice lost weight after infection with T. gondii, irrespective of the geno-
type or the infection dose. Weight loss and dose of infection were positively corre-
lated, except for high-dose challenges with virulent clones which killed the mice 
rapidly. In contrast, mice infected with low-virulent T. gondii clones and negative 
control animals lost only up to 5.00% of weight. Infection with high doses (106 
and 104 parasites) of high-virulent clones (groups 2 and 4) led to weight losses of 
only up to 10.00%, but the animals died within 2–3 days after the onset of dis-
ease. However, mice infected with lower doses of high-virulent clones had lost 




30%. Some animals showed a rapid decrease from less than 20.00% to 30.00% 
weight loss within one day (Figure 15).  
Detailed analysis of maximal weight losses between the clones showed that 
infection with T. gondii was almost always statistically significantly correlated 
with weight loss as compared to control groups. However, this phenomenon could 
only be associated with the non-canonical genotypes. Type II wild-type isolates 
K106, K107 and K126 did not show a significant difference in terms of weight 
loss as compared to the control group (Figure 16A). Despite a statistically signifi-
cant maximum weight loss compared with the control animals, infection with T. 
gondii clones K119/2 2-H8 did not result in any death of the infected mice and the 
weight of the infected animals increased at the end of the experiment. Statistical 
differences in terms of maximum weight loss in the high virulence groups are also 
misleading since these animals died rapidly within a few days. The weight loss 
was therefore not as pronounced as in challenge infections with 104 tachyzoites 
(Figure 16B). Challenge with 104 virulent T. gondii clones resulted in statistically 
significant weight loss in all infected mouse groups as compared to control ani-
mals (Figure 16B). Mice infected with 102 T. gondii tachyzoites of clone K119/2 
A7 showed hardly any weight loss. Surprisingly, the virulent T. gondii clone 
B136/1 A3-F5 showed not statistically significant differences in terms of weight 
loss at this dose. However, mice in that group all died late but lost a considerable 
amount of weight within only two days after the onset of symptoms. All other 
mice infected with virulent T. gondii clones showed significant weight loss as 
compared to the control animals (Figure 17A). Upon challenge with 10 tachyzo-
ites, the extremely highly virulent T. gondii clone B136/1 B6-H6 caused statisti-
cally significant weight losses in infected mice. Interestingly, animals infected 
with B136/5 G12 also showed higher weight loss than observed in control animals 
(Figure 17B). 
When analysing weights of organs from infected and control animals, only 




lungs, brains or kidneys of infected animals were not significantly different com-
pared to those of control mice (data not shown). Almost all mice infected with 106 
T. gondii clones suffered from splenomegaly as a result of acute infection with T. 
gondii (Figure 18A). Spleens of all infected mice were considerably enlarged. 
Interestingly, mice infected with the high-virulent T. gondii clone B136/5 G12 did 
not show statistically significant enlarged spleens. However, mice in that particu-
lar group died extremely fast shortly after infection. In mice infected with 104 
tachyzoites, spleens were enlarged in almost all mouse groups regardless of the T. 
gondii genotype they were infected with (Figure 18B). All mice infected with 100 
tachyzoites of high-virulent T. gondii showed statistically significant enlarged 
spleens (Figure 19A). At the lowest dose of infection (10 T. gondii tachyzoites), 
only animal groups with the highest number of survivors (T. gondii clones B136/2 
C12 and B136/5 G12) showed significant differences in their spleen weight as 
compared to control animals. Mice infected with 10 tachyzoites of high-virulent T. 
gondii clones (B136/1 B6-H6 and B136/1 A3-F5) showed no differences com-
pared with the control animals (Figure 19B). 
When the route of in-vivo isolation was analysed, it became apparent that all 
highly mouse-virulent clones had been passaged through BALB/c mice prior to 
in-vitro isolation, while all clones isolated after a GKO-mouse passage were of 







Figure 16: Maximum changes in weight of BALB/c mice infected with (A) 106 or (B) 104 T. 
gondii tachyzoites i.p.  
Five BALB/c mice per T. gondii clone were each infected with (A) 106 tachyzoites i.p. or (B) 104 
tachyzoites i.p. Whiskers: 95% CI; *: statistically significant differences (P < 0.05, Mann-Whitney 





Figure 17: Maximum changes in weight of BALB/c mice infected with (A) 100 or (B) 10 T. 
gondii tachyzoites i.p.  
Five BALB/c mice per T. gondii clone were each infected with (A) 100 tachyzoites i.p. or (B) 10 
tachyzoites i.p. Whiskers: 95% CI; *: statistically significant differences (P < 0.05, Mann-Whitney 





Figure 18: Maximum changes in spleen weight of BALB/c mice infected with (A) 106 or (B) 104 
T. gondii tachyzoites i.p.  
Five BALB/c mice per T. gondii clone were each infected with (A) 106 tachyzoites i.p. or (B) 104 
tachyzoites i.p. Whiskers: 95% CI; *: statistically significant differences (P < 0.05, Mann-Whitney 





Figure 19: Maximum changes in spleen weight of BALB/c mice infected with (A) 100 or (B) 10 
T. gondii tachyzoites i.p.  
Five BALB/c mice per T. gondii clone were each infected with (A) 100 tachyzoites i.p. or (B) 10 
tachyzoites i.p. Whiskers: 95% CI; *: statistically significant differences (P < 0.05, Mann-Whitney 




3.3 Virulence markers 
The typing results for putative mouse virulence markers were compared and 
tested for agreement with the actual in-vivo virulences obtained from experimental 
infections. Predictions using the virulence marker CS3 corresponded perfectly 
with the predictions of UPS-ROP18 (Table 21). UPS-ROP18 was absent (type 
I/II) in all representatives of clone groups 4 and 5 (LD50 < 100 tachyzoites) which 
correctly predicted their high virulence for mice. UPS-ROP18 was present (UPS-
ROP18III*) in representatives of clone group 1 (LD50 > 106 tachyzoites) which 
correctly predicted their low virulence for mice. However, UPS-ROP18 was ab-
sent in representatives of clone group 3 (LD50 > 106 tachyzoites), thus predicting 
high virulence for mice, which is in contrast to their low virulence for BALB/c 
mice. Representatives of clone group 2 showed intermediate (LD50 > 102 tachyzo-
ites) and high (LD50 > 10 tachyzoites) virulence for BALB/c mice despite the 
presence of UPS-ROP18 and CS3 type III, which have been proposed as predic-
tors of low mouse virulence [Khan et al., 2009].  
The clones described here showed a positive correlation between virulence 
and the PK1 allele as determined by PCR-RFLP. All mouse-virulent clones had a 
type II allele at the PK1 locus, whereas non-virulent clones had a type III allele 
present at this locus. 
DNA sequencing of the UPS-ROP18 was carried out to identify possible se-
quence differences between virulent and non-virulent UPS-ROP18III* and to de-
termine the UPS-ROP18 type in T. gondii clones groups 3–5 identified as UPS-
ROP18I* or ROP18II*. All T. gondii clones that had the UPS-ROP18 absent were 
of UPS-ROP18II* as indicated by an additional 44 bp repeat which is absent in 
UPS-ROP18I*. However, no difference were detected between the UPS-
ROP18III* sequences of T. gondii clones with high and low virulences for 






















































































































































































































































































































































































































3.4 Analysis of additional chromosomal markers 
To investigate whether T. gondii clones of different allelic patterns were 
the result of a recombination event or of a re-assortment of chromosomes in the 
definitive host, additional chromosomal markers were studied in one or two 
clones from each clone group (Table 22). No allelic type differences were ob-
served between the genetic markers used for genotyping and the additional chro-
mosomal markers in T. gondii clones of clone groups 1 (K119/2 2-H8, K119/2 2 
F3-A3) and 2 (K119/2 A7, B136/2 C12). Interestingly, T. gondii clones of clone 
group 3 (K119/2 2-C10, K119/2 G11-C4) showed alleles of different types on 
Chr.V, while type III alleles were observed on this chromosome using the genetic 
marker L358 and type II allele was detected using the genetic marker AK22. 
Clones in clone group 4 (B136/5 G12, B136/1 B6-H6) and 5 (B136/1 A3-F5) had 
a type III allele at locus c29-2, but a type II allele at locus AK97, both of which 
are located on Chr.III. Furthermore, a type II allele was observed at the nSAG2 























































































































































































































































































































































































































































































































3.5 Analysis of human samples 
A total of nine DNA samples from patients with ocular toxoplasmosis (TG-
hssGER01–09) and two DNA samples from patients with congenital toxoplasmo-
sis (TG-hssGER10–11) were available for analysis.  
Of the nine samples from patients with ocular toxoplasmosis only five (TG-
hssGER01, 03, 04, 06 and 08) were weakly positive for T. gondii-DNA using con-
ventional PCR detecting the 529 bp repeat region of T. gondii (TOX5/Tox-8 pri-
mer). Therefore, the T. gondii-DNA content in the samples was deemed to be very 
low. Because of the small amount of DNA in the samples a multiplex-PCR was 
used to amplify the nine genetic marker regions for genotyping. As expected, only 
partial genotyping was possible for samples that were positive in the conventional 
T. gondii-PCR. In the sample TG-hssGER01, only three T. gondii type II alleles 
were detected at loci c22-8, L358 and Apico. Interestingly, in sample TG-
hssGER03, alleles of either T. gondii type I or III were detected at loci GRA6 and 
PK1. In samples TG-hssGER04 and 07, the highest number of loci could be PCR-
amplified. The yield was low, however, with only 3/9 loci. In both cases, only 
alleles of T. gondii clonal type II were observed. While sample TG-hssGER04 was 
successfully genotyped at the loci newSAG2, SAG3 and PK1, in TG-hssGER07 
loci BTUB, GRA6 and L358 could be PCR-amplified. All results are summarised 
in Table 23.  
All T. gondii-DNA samples from patients with congenital toxoplasmosis 
could be completely typed for all selected markers. Both samples showed alleles 
of type II except for the Apico locus where a type I allele was observed as summa-





Another sample containing vitreous liquid of a patient with ocular toxo-
plasmosis was supplied by Prof. Pleyer (Charite, Berlin). The sample was centri-
fuged at 1,100 x g; 7 min without brake. The supernatant was removed and the 
pellet resuspended with 100 µl DMEM. Half of the resulting solution was used to 
isolate parasite DNA using the Nucleospin Tissue kit (Macherey-Nagel). The re-
maining 50 µl were filled up to 500 µl with DMEM medium and used to inoculate 
a GKO-mouse i.p.. At three months p.i. no symptoms were observed in the inocu-
lated mouse. Serum collected at 90 d.p.i. was seronegative for T. gondii. Further-
















































































































































































































































































































































































































































































































































































































































































































































































































4.1 T. gondii genotypes in cats in Germany 
Most studies on T. gondii in Germany have concentrated on serological in-
vestigations in livestock animals so far. Together with results on oocyst shedding 
and genotyping of T. gondii in cats the work presented here tries to give a more 
comprehensive overview of T. gondii genotypes in cats in Germany.  
The aim of this study was to characterise the genotypes of T. gondii oo-
cysts obtained from feline faecal samples. To achieve this, 82 new T. gondii oo-
cyst isolates from feline faecal samples were collected and analysed in addition to 
22 isolates which were already available from a previous study [Schares et al., 
2008b]. Among the resulting total of 104 isolates there were four isolates with 
non-canonical or mixed T. gondii genotypes. To the best of our knowledge, T. 
gondii isolates of such non-canonical and mixed infections have never been de-
tected in Europe before and have never been observed in the faeces of naturally 
infected cats worldwide. For the first time, genetically different non-canonical T. 
gondii of high and low mouse virulence excreted by a single naturally infected 
feline host were found and characterised. However, there was no evidence of atyp-
ical T. gondii or isolates carrying atypical alleles shed by cats from Germany. 
Although 18,259 feline faecal samples were examined and statistically an-
alysed, this study cannot be regarded as population-wide or representative in 
terms of its spatial distribution (e.g. urban or rural), cat ownership (e.g. private or 
farm) or cat feeding (e.g. commercial feed, mice, birds) because cat owners and 
veterinarians submitted these samples to diagnose diarrhoea (in about 60.00% of 
the cases) or for routine testing. However, no temporal constraints were placed on 
this study; therefore it is representative of the temporal distribution of cats shed-




The results show that for the period June 2007–December 2008 only 
0.25% of the feline faecal samples were T. gondii-positive. Interestingly, the pro-
portion of T. gondii-positive samples collected between January and June (0.09%) 
was significantly lower than between July and December (0.31%). This may indi-
cate that the risk for intermediate hosts (including humans) to acquire a T. gondii-
infection via oocysts could vary over the year, being highest in the second half of 
the year. Such seasonality may at least in part be due to the availability of infected 
prey (e.g. rodents, birds) to cats. If the risk of infection for prey, e.g. via oocyst 
contamination in the environment, and an increased number of prey early in the 
second half of the year is assumed, the chance of a cat to eat infected prey and to 
shed oocysts will also increase in this part of the year. However, this seasonality 
only applies to cats shedding T. gondii oocysts.  
Due to data protection we cannot draw any conclusion on whether the 
studied cats were fed raw or not appropriately treated meat products (in contrast to 
tinned food) or whether they were allowed to roam outside. This is important to 
take into account when analysing seasonality.  
Cats that roam outside may be exposed to additional risks of acquiring T. 
gondii by hunting and eating infected birds or small mammals (such as rodents). 
However, the seroprevalence of T. gondii in mice from the Federal State of Bran-
denburg was shown to be very low (0.00%) [Herrmann et al., 2012]. Pigeons from 
Portugal had a 62.50% T. gondii prevalence [Waap et al., 2008]. More important-
ly, the seroprevalences reported in rodents vary greatly. The T. gondii-DNA preva-
lence in Austria was shown to be only 0.70% in Microtus arvalis [Fuehrer et al., 
2010]. In Switzerland, the T. gondii seroprevalence was also found to be low, with 
3.00% Microtus arvalis and 5.00% of Arvicola terrestris being seropositive for 
this parasite [Reperant et al., 2009]. In contrast, shrews (Sorex spp.; 60.00%), 
voles (A. terrestris; 22.00%) and moles (Talpa europaea; 39.00%) from France 
showed high seroprevalences [Afonso et al., 2007]. Interestingly, a high T. gondii 




Kingdom that were captured as part of a pest control programme in domestic 
dwellings in Manchester [Hughes et al., 2006].  
Since there was no information on the behaviour of cats analysed in this 
study, it is difficult to identify the sources of infection for cats in Germany. Stud-
ies on cats in urban areas also suggest that there were sites where cats preferred to 
defecate [Afonso et al., 2008]. Therefore, hot spots in terms of sites contaminated 
with T. gondii oocysts may exist. Other sources of T. gondii infections for cats 
could therefore also include oral uptake of oocyst-contaminated soil, food sources 
or water. Another possible but unlikely source of infection may be earthworms 
which have been described as parantenic hosts of T. gondii [Afonso et al., 2007; 
Ruiz and Frenkel, 1980].  
A recent study on T. gondii in foxes from Germany showed that the sero-
prevalence was up to 85.00% [Herrmann et al., 2012]. This indicates that T. gondii 
must be present in German wild life and that the sylvatic life cycle of T. gondii is 
quite complex, possibly involving many different mammals and birds capable of 
transmitting the parasite. Oocysts deposited on soil also do not stay but may be 
washed off. Recent studies using T. gondii oocyst surrogates showed that land-
scape changes caused by man and/or nature facilitate run-off and thus increase the 
transport of oocysts. This effect was shown to be intensified by extensive dry pe-
riods and may increase with increasing temperatures [Shapiro et al., 2010a; 
Shapiro et al., 2010b]. 
A large proportion (47.06%) of T. gondii shedding cats was over 12 months 
old. Moreover, a number of cats older than seven years (10/34; 29.42%) were 
found to shed T. gondii oocysts. This finding confirms an earlier report indicating 
that older cats shed T. gondii oocysts more often than previously thought [Schares 
et al., 2008b]. Lack of data regarding the habits of the older cats and the condi-
tions the cats were kept in made it impossible to draw any conclusions on the rea-




shed oocysts again even years after their first shedding event. Superinfection 
could be another possibility why older cats were found to shed T. gondii oocysts. 
[Dubey, 1995; Frenkel and Smith, 1982; Lappin et al., 1996]. Of course, it is also 
possible that the old oocyst-shedding cats observed were infected for the first time 
in their life. 
Most T. gondii samples originated from areas with a high population densi-
ty. However, this may only reflect areas where most samples came from. This was 
shown by the fact that the random sample of cats negative for oocyst shedding 
that was investigated in this study had also been submitted from these areas. As 
far as we know, all faecal samples were submitted to VetMed Labor GmbH either 
by the owner or the veterinarian. Therefore we can assume that the cats sampled 
were most likely domestic cats. However, this does not rule out any contact of the 
cats with the sylvatic cycle of T. gondii in Germany. 
In this study, previous work [Schares et al., 2008b] on T. gondii oocysts by 
faecal samples over a period of over three years was extended. T. gondii isolates 
were all characterised using nine molecular markers (newSAG2, BTUB, GRA6, 
SAG3, c22-8, c29-2, L358, PK1 and Apico). When comparing the results of the 
previous study with the work presented here, it is evident that the use of a single 
locus or even four loci does not give sufficient information to determine the T. 
gondii genotype unambiguously. Isolates previously described as type II were 
found to contain non-type II alleles at additional loci using another five genetic 
markers for PCR-RFLP. The correctly designated non-canonical isolates provide 
important information regarding the genetic diversity of T. gondii in Germany.  
The majority of T. gondii oocysts shed by cats had type II-specific allele pat-
terns. This confirms previous findings indicating that human congenital toxoplas-
mosis in Europe is mainly caused by type II T. gondii [Ajzenberg et al., 2002a; 
Aspinall et al., 2003; Fuentes et al., 2001; Honore et al., 2000; Howe et al., 1997; 




I at the Apico locus with only a few having a type II pattern at this locus. When 
the Apico marker was first described, the type II isolate DEG which had been iso-
lated from a French patient with latent congenital toxoplasmosis [Darde et al., 
1992], was also characterised as type I at the Apico marker region [Su et al., 
2006]. T. gondii with type II alleles at all chromosomal loci but with type I at the 
Apico locus have also been observed by others [Berger-Schoch et al., 2011a; 
Dubey and Jones, 2008; Prestrud et al., 2008]. The apicoplast is a secondary en-
dosymbiont and inherited via the maternal line [Ferguson et al., 2005]. Therefore, 
our observation would only fit to the model that clonal type I has arisen from just 
a few crosses between ancestral type II parents and other ancestral strains (pater-
nal) [Saeij et al., 2006] if two lineages of type II strains exist (one with a type I 
and the other with a type II apicoplast) and only the one with a type I apicoplast 
contributed to the rise of type I. However, to confirm the validity of the Apico 
PCR-RFLP marker used in the present study and to determine the maternal inher-
itance of the many isolates, more sequence data on the apicoplast genomes of 
clonal types I and II strains are needed. 
Only one T. gondii isolate from feline faecal samples was of type III and 
none of type I. Considering that 38,576 cat samples were examined in total (June 
2007–December 2008), the confidence intervals indicate that the true prevalence 
of T. gondii type I in our target cat population is lower than 0.008%. Therefore, it 
may be concluded that type I and type III are relatively rare in cats from Germany 
or even absent (type I). 
Other European countries, such as Spain, Portugal or Poland, reported T. 
gondii clonal types genetically different from type II in humans [Ajzenberg et al., 
2005; Grigg et al., 2001b] and animals such as chickens [Dubey et al., 2008b], 
pigs [de Sousa et al., 2006] and pigeons [Waap et al., 2008]. This situation may be 
explained by an uneven spatial distribution of T. gondii types I and III within Eu-




example, high mountain ranges separate the Iberian Peninsula from the rest of 
Europe.  
The first early maritime trading activities took place between South America 
and the Iberian Peninsula, where non-type II T. gondii are observed. However, 
some of the largest modern-day ports are situated in the Netherlands and Germany 
and increased international and European trade importing meat and pets should 
have established non-type II in Germany. Surprisingly, non-canonical types of T. 
gondii were identified in chickens in the neighbouring country Poland [Dubey et 
al., 2008b]. Another study suggests that non-canonical T. gondii-DNA was found 
in cattle from Switzerland [Berger-Schoch et al., 2011b]. This may indicate that 
non-type II T. gondii could circulate in some intermediate host species (domestic 
or wild animals). However, T. gondii was not isolated in these studies but only 
DNA samples from tissue analysed. Without typing a T. gondii isolate, one cannot 
be sure that the tissue did not harbour different types of T. gondii while only one 
of the alleles was PCR-amplified from the sample. Another study on T. gondii in 
foxes from Germany found predominately type II but there was evidence of mixed 
T. gondii-type infection and non-canonical types circulating in wild animals in 
Germany [Herrmann et al., 2012]. Moreover, the T. gondii genotype patterns ob-
served in oocyst-shedding cats probably reflect only a fraction of the whole spec-
trum of genotypes present in Germany. In this country, genotyping of T. gondii 
was carried out for isolates and T. gondii-DNA of tissues from cats, foxes and 
humans so far. To get a clearer picture of the population structure of T. gondii, 
more intermediate host species need to be investigated. Of particular interest 
could be infected migrating birds that may introduce new genotypes from coun-
tries which have a more genetically diverse T. gondii population structure, such as 
Brazil, into Germany. 
Among all T. gondii isolates, we found only four with non-canonical and 
mixed genotypes, if the results for the Apico marker are not taken into considera-




type at a single locus, may indicate the presence of a mixed population in the re-
spective oocyst sample. The presence of a mixed population can be explained by 
sexual recombination or re-assortment of chromosomes during a sexual cross after 
simultaneous infection of a cat with T. gondii isolates of different genotypes. Suc-
cessive experimental infection with two strains of different genotypes was shown 
to be possible in mice [Araujo et al., 1997; Dao et al., 2001]. This suggests that 
recombination between different T. gondii types in a cat after ingesting only one 
intermediate host harbouring two different T. gondii genotypes would be possible.  
The sample TG-GER63 showed a pattern consisting of a mixture of type II- 
and III-specific alleles scattered over several loci and chromosomes which would 
be consistent with this interpretation. However, sexual recombination is believed 
to occur very seldom in nature while self-mating of T. gondii seems to be one of 
the predominant routes of reproduction. This is regarded as one of the reasons for 
the clonal population structure of T. gondii observed in North America and Europe 
[Grigg and Sundar, 2009]. There is increasing evidence that sexual recombination 
may play an important role in the evolution and diversification of T. gondii strains 
in nature [Ajzenberg et al., 2004; Dubey, 2008; Dubey and Jones, 2008; Dubey et 
al., 2008c; Grigg and Suzuki, 2003], especially in South America [Pena et al., 
2008], Africa [Lindström Bontell et al., 2009; Lindström et al., 2008; Mercier et 
al., 2010; Velmurugan et al., 2008] and Asia [Dubey et al., 2007h; Dubey et al., 
2008b; Zhou et al., 2009; Zhou et al., 2010]. Mixed genotypes can be induced 
experimentally [Saeij et al., 2006; Taylor et al., 2006] by crossing different T. 
gondii types in-vitro and in-vivo. In countries where domestic felids are absent, 
wild felids, such as Jaguars in French Guiana, may serve as definitive hosts 
[Demar et al., 2008]. This indicates that there might be both, a domestic and a 
wild (sylvatic) cycle. Observations of mixed genotypes in indigenous prey, such 
as free-ranging chickens in South America [Dubey et al., 2005b; Dubey et al., 
2005c; Dubey et al., 2006a; Dubey et al., 2006b; Dubey et al., 2006c; Dubey et 




al., 2008], deer in the USA [Dubey and Jones, 2008; Dubey et al., 2008f], cou-
gars, raccoons and skunks in the Boreal forests of Canada [Dubey et al., 2007g; 
Dubey et al., 2008c] indicate the importance of the sylvatic cycle as a driving 
force for genetic diversity in T. gondii. 
4.2 Non-canonical T. gondii have high virulences in BALB/c mice 
In this study, a number of genetically different, non-canonical T. gondii 
clones were isolated from a single faecal sample of a naturally infected cat. To our 
knowledge, this is the first report showing that sexual recombination in a natural 
infected cat may have led to the generation of genetically different T. gondii. More 
importantly, these non-canonical T. gondii types show differences in virulence for 
BALB/c mice. We identified high-virulent as well as low-virulent T. gondii. Viru-
lence for BALB/c mice differed not only between genotype groups (nine PCR-
RFLP marker regions) but interestingly also between T. gondii clones within the 
same genotype group. 
The only previous report with indications for a natural sexual recombination 
or re-assortment of chromosomes in T. gondii came from Uganda [Lindström et 
al., 2008]. Sequencing the reported natural type II/III T. gondii (TgCkUg2) re-
vealed that this isolate has arisen via chromosome sorting and not via interchro-
mosomal recombination, possibly through a single sexual cross of type II and type 
III T. gondii. Interestingly, this isolate caused a significantly higher parasite densi-
ty in mice as compared to a related type II isolates but did not reach the compara-
tively high parasite density of a type III isolate. It was concluded that this viru-
lence potentiation was achieved by a sexual cross, and that the increased virulence 
was due to the identified virulence loci [Lindström Bontell et al., 2009]. Examina-
tion of another T. gondii isolates from chickens and cats in a waterborne toxo-
plasmosis outbreak in Brazil found several T. gondii genotypes which may have 
been the result of a sexual recombination event. However, this study was based on 




Furthermore, T. gondii possesses virulence genes that show an altered bio-
logical potential in recombinant strains [Sibley and Ajioka, 2008]. Certain alleles 
of the genes ROP18 (located on Chr. VIIa) and ROP16 (located on Chr. VIIb) 
have virulence-potentiating properties [Saeij et al., 2006; Taylor et al., 2006]. 
Analysis of T. gondii strains from different geographical regions of the world dis-
covered that only three major alleles of this gene (ROP18I*, ROP18II* and 
ROP18III*) were evident world-wide, corresponding to types I, II and III, respec-
tively [Khan et al., 2009]. More importantly, the majority of South American iso-
lates share alleles of the ROP18I* gene which is associated with high virulence in 
mice. Isolates of the ROP18III* type had an upstream region (UPS-ROP18) which 
was absent in isolates of the ROP18II* and ROP18I* type. Virulence data of the 
isolates showed that almost all isolates of the ROP18III* type were avirulent in 
mice whereas absence of UPS-ROP18 (ROP18I* and ROP18II*) was associated 
with higher virulence in mice. However, there were notable exceptions to this 
rule. Although UPS-ROP18 was present, and thus the isolates should have been of 
low virulence, the T. gondii isolates P89 and CAST were in fact shown to be high-
ly virulent for mice [Khan et al., 2009]. In the current study, representatives of T. 
gondii clone group 2 (B136/2 C12 and K119/2 A7) seem to confirm this. Although 
these isolates were of the ROP18III* (“avirulent”) type, they caused high mortali-
ty in BALB/c mice. To confirm that the UPS-ROP18 region was really present, 
the UPS-ROP18 region was sequenced in B136/2 C12 and K119/2 A7. Both viru-
lent T. gondii clones were confirmed to be of the UPS-ROP18III* type and the 
sequence was shown to be identical to the “avirulent” T. gondii type III (VEG) 
reference strain. According to the virulence markers, T. gondii of the ROP18I* or 
the ROP18II* type should be mouse-virulent [Khan et al., 2009]. However, the 
present study does not fully agree with this hypothesis since T. gondii isolates 
with a low virulence for BALB/c mice (clone group 3; K119/2 2-C10 and K119/2 
G11-C4) were all of the ROP18II* type as confirmed by DNA sequencing. It was 
therefore concluded that the published virulence markers [Khan et al., 2009] can 




clones. The presence or absence of UPS-ROP18 in different T. gondii isolates 
does not seem to be associated with mouse virulence. Other factors must therefore 
confer virulence in type I T. gondii parasites. It was shown that there is variation 
in the expression of ROP18 between the different T. gondii clonal types. While 
expression of ROP18 is increased in T. gondii type I and II, it was shown to be 
lower in T. gondii type III [Saeij et al., 2006].  
Recent investigations into the action of ROP18 have further elucidated its 
function in mouse virulence. ROP18 is a member of the ROP2 gene family ex-
pressed during invasion of T. gondii. It is one of the contributors to resistance of 
type I strains to the IRG system in mice. When “avirulent” T. gondii strains active-
ly invade cells they form a PVM and within minutes IFN-γ-stimulated cells ex-
press IRG proteins (Irgb6 and Irga6) that accumulate at the PVM. As a result, the 
PVM starts to disrupt and to disintegrate [Pawlowski et al., 2011; Virreira et al., 
2011]. However, only type I strains were shown to inhibit this process. The 
ROP18 protein of type I was able to directly phosphorylate mouse IRG proteins at 
two conserved threonine residues in an important nucleotide binding domain. As a 
result, the GTPase is catalytically inactivated and thus unable to locate and to bind 
to the PVM. The authors concluded that only T. gondii expressing the active form 
of ROP18, like type I strain do, will evade IRG-killing. It was also found that type 
II ROP18 only differs from type I in 22 amino acids, whereas type III differs from 
type I in 78 amino acids. However, since the expression level of ROP18 in type III 
T. gondii is greatly reduced, this might be another reason for the greatly reduced 
virulence of type III in mice [Steinfeldt et al., 2010]. Forward genetics has con-
firmed the mode of action of ROP18. T. gondii type III expressing active type I 
ROP18 were shown to be mouse virulent in contrast to the wild-type type III. The 
level of secreted ROP18 on the PVM was shown to be inversely correlated to 
Irgb6 staining at the PVM. Thus high levels of ROP18 blocked recruitment of 
IRG to the PVM [Fentress et al., 2010; Fentress and Sibley, 2011]. Other re-




lum-bound transcription factor ATF6β triggering its degradation. Normally this 
transcription factor activates the expression of genes harbouring an unfolded pro-
tein response element (UPRE). By inactivating this factor in dendritic cells, T. 
gondii might downregulate the UPRE-mediated host defence. However, the exact 
target and mechanism remains to be elucidated [Yamamoto et al., 2011]. 
ROP16, another member of the ROP2 kinase family, was shown to influ-
ence the JAK/STAT pathway during an active T. gondii infection. Recombinant 
ROP16 was shown to phosphorylate STAT6. However, only T. gondii type I and 
III, but not type II, can maintain a STAT3/STAT6 activation. A single SNP chang-
ing a Leucine to a Serine was shown to change the kinase pocket of ROP16 in 
type II parasites thus disabling its action. Activation of STAT3/6 leads to reduced 
IL-12, IL-10 and TNF-α expression by APCs. This in turn leads to a decrease in 
IFN-γ release and thus reduced killing of the parasite in T. gondii type I and II 
[Melo et al., 2011; Ong et al., 2010]. 
Another virulence factor was identified as ROP5 which is expressed by all 
known T. gondii isolates, yet the mechanism differs from that of ROP18. ROP5 
seems to be expressed as a single protein and comes in three different isoforms, A, 
B. and C. It is also encoded by a locus of tandemly duplicated genes that are high-
ly polymorphic. Allelic variation of the isoforms was shown to be responsible for 
a 5-logs difference in virulence in a mouse model [Reese et al., 2011]. Further-
more, type I and type III were shown to be nearly identical and to possess the 
virulent clusters of ROP5 (5–6 copies), in contrast to type II (9–10 copies). A 
frameshift in type II ROP5B seemed to result in a non-functional protein. Experi-
ments further revealed that the ROP5 locus is not a single functional unit and that 
an individual isoform can significantly alter virulence in the absence of the other 
copies. T. gondii type I that had their functional ROP5 removed were shown to be 
non-virulent. Inserting copies of either isoform of type III ROP5A or ROP5B res-
cued the previously lost virulence. Bearing in mind that ROP18 was still function-




As the ROP5 proteins are present on the cytosolic face of the PVM, they may in-
teract with and thus, deregulate host proteins that are the key to the immune re-
sponse. However, no target or mode of action has been revealed so far [Behnke et 
al., 2011; Reese and Boothroyd, 2011; Reese et al., 2011].  
It appears, however, that virulence does not necessarily require the inher-
itance of specific alleles but that reshuffling [Grigg and Sundar, 2009] of existing 
alleles at only a few loci may be sufficient to produce new generations with dif-
ferent biological traits [Grigg and Boothroyd, 2001; Grigg and Suzuki, 2003]. 
Virulence may thus be a quantitative trait involving many loci; and the virulence 
of T. gondii could vary depending on the expressed dominant loci and on the spe-
cific combination of alleles at the contributing loci which reassort in a crossing 
event [Grigg and Sundar, 2009].  
Importantly, all virulence studies published to date were performed in 
mouse-models, so no conclusions can be drawn as to the virulence of T. gondii 
isolates in humans or other host species. The present study showed that highly 
virulent non-canonical T. gondii isolates exist or can be formed in Germany. What 
we do not know is where the oocysts go after being shed by cats and whether the 
described genotypes can persist in certain host species. This study may be a start-
ing point for more investigations to answer such questions. Are the virulent T. 
gondii clones able to be passed on to other hosts or do they kill wild-type mice or 
other intermediate host species readily as observed in laboratory mice? If they do 
so, can they be transmitted to other hosts that are not killed by the parasite, and 
thus persist in those species?  
It seems that a range of different virulence factors determines mouse viru-
lence. So far, the T. gondii clones identified in this study were only analysed for 
UPS-ROP18. Future studies will focus on determining the expression levels of 




of T. gondii regarding the activation of STAT3/6 and IRGs phosphorylation will 
also need to be addressed. 
 
4.3 T. gondii in humans from Germany 
In contrast to France, screening of pregnant women and new-borns is not 
compulsory in Germany. Therefore, early detection of human toxoplasmosis is 
difficult. Furthermore, most infections with T. gondii do not cause clinical symp-
toms and are therefore not detected. All those factors result in very few biopsy 
samples from patients with toxoplasmosis. Only few samples from patients infect-
ed with T. gondii were therefore available for this study.  
Nevertheless, this is the first study to genotype DNA-samples from patients 
with ocular toxoplasmosis in Germany. Almost all samples from patients showed 
alleles of T. gondii type II. This reflects the high prevalence of type II in Europe. 
Since we do not have any information regarding the clinical manifestations in the 
patients or their age we could not analyse possible associations between genotype 
and clinical outcome in this group of patients. Previous work suggested that non-
canonical or atypical T. gondii genotypes were more prevalent in human cases of 
ocular toxoplasmosis. For the small patient group that was analysed in this study, 
this hypothesis could not be confirmed. However, the sample size was far too 
small to draw any final conclusion for Germany.  
No data on the onset of symptoms were obtained. It would have been inter-
esting to compare our data on the seasonality of T. gondii oocyst shedding by cats 
to the onset of clinical symptoms in these patients. A study from Serbia revealed 
that the onset of symptoms such as lymphadenopathy in 39 patients was highest in 
spring and in October/December, which correlates with our data on T. gondii oo-
cyst shedding by cats [Bobic et al., 2010]. Our results also showed that although 




served in most clinical samples. As already noted in cats, the mere presence of T. 
gondii-DNA as detected by the diagnostic primers of the 529 bp-repeat regions is 
no guarantee that genotyping can be achieved. Bearing in mind that the diagnostic 
PCR targets is a repeat region [Homan et al., 2000; Reischl et al., 2003] this 
seems to be plausible. All genetic regions used for genotyping are based on single 
copy genes. Thus, detection of these marker regions requires relatively large 
amounts of DNA. In clinical samples this is not always the case. Genotyping tis-
sue samples of cattle and sheep from Switzerland and of foxes from Germany also 
highlighted the problem [Berger-Schoch et al., 2011b; Herrmann et al., 2012] of 
obtaining enough DNA to amplify all genetic marker regions to achieve complete 
genotyping. From the few loci that were PCR-amplified we cannot confirm that 
ocular toxoplasmosis is preferentially caused by non-canonical or atypical T. 
gondii in Germany. Several reports suggest that ocular toxoplasmosis is often as-
sociated with T. gondii of atypical genotypes in the USA [Grigg et al., 2001b]. 
Considering that type II is also predominately found there, we would have ex-
pected similar results for Germany. Genotyping 13 out of 20 patients from France 
using microsatellite markers showed that most patients with ocular toxoplasmosis 
were infected with T. gondii type II (n = 10). Importantly, three patients showed 
infections with T. gondii types different from type II. One patient showed alleles 
of types II and III, whereas the T. gondii haplotype Africa 1 was identified in two 
patients. These two patients had a sub-Saharan background or had travelled to 
China and India a few years previously. This strongly suggested that the patients 
had contracted the infection with T. gondii whilst living in these countries. How-
ever, no association of atypical or non-canonical T. gondii in patients with ocular 
toxoplasmosis could be determined [Fekkar et al., 2011]. Reports suggest atypical 
and other genotypes may be responsible for severe ocular toxoplasmosis in South 
America, Korea and China [Alves et al., 2010; Quan et al., 2008]. Considering 
that the overall prevalence of such atypical T. gondii genotypes is higher in those 
countries compared to the European/North American situation, it is not surprising 




non-canonical T. gondii genotypes in British toxoplasmosis patients is remarkable 
[Aspinall et al., 2003]. Unfortunately, the ethnic background of the patients was 
not mentioned in the study. They may therefore have observed theses atypical T. 
gondii genotypes in patients with different ethnic background or in patients with 
extensive travelling history around the world. 
An alternative method to circumvent the difficulty of obtaining enough bi-
opsy material for genotyping is serotyping patient sera. Serotyping is based on 
detecting type-specific differences in short immunodominant regions of proteins 
(peptides) that are recognised by the immune system. These peptides are 10–20 
amino acids long and can be used in ELISA or microarray assays. Antibodies 
against type-specific T. gondii peptides contained in the serum of infected patients 
bind to such peptides. Depending on the recognised peptides, the serotype of T. 
gondii can be determined [Kong et al., 2003]. However, the technique is not well 
established and only small numbers of peptides are validated. Such a small num-
ber of peptides are not enough to reliably predict the T. gondii genotype a patient 
is infected with. Studies on serotyping can only give a general perspective on the 
population as a whole. Recent studies comparing the peptide profiles of T. gondii 
infected patients from Europe and those recognized by patients from South Amer-
ica showed that most patients in Europe reacted with peptides specific for T. 
gondii type II. In contrast, patients from Colombia showed positive reactions to 
peptide specific for type I and type III, confirming some reports on genotyping 
patients from Europe [Morisset et al., 2008; Nowakowska et al., 2006; Peyron et 
al., 2006; Sousa et al., 2009]. Results using a newly developed microarray plat-
form for serotyping confirm findings of other groups in Europe and the high prev-
alence of type II specific peptides recognised by T. gondii infected patients from 
Germany [Maksimov, 2012]. 
To properly address the question of T. gondii genotypes in toxoplasmosis 
patient in Germany, a concerted effort is needed by all institution diagnosing tox-
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Alignment of DNA sequences of T. gondii type I (GT1), type II (ME49), type III (VEG) compared 
to DNA sequences obtained by sequencing the upstream region of ROP18 of T. gondii clones 
K119/2 2-H8, K119/2 A7, B136/2 C12, K119/2 2-C10, K119/2 G11-C4, B136/5 G12, B136/1 B6-
H6; and B136/1 A3-F5. Primer binding sites are underlined; The UPS-ROP18 elements (508 bp 
element, 44 bp repeat element, UPS, 99 bp element, 109 bp element, ROP18 protein coding re-
gion) described by [Khan et al., 2009] are annotated and indicated by a grey background:. 
                             10        20        30        40 
                    ....|....|....|....|....|....|....|....| 
Annotations                    ROP18-1F     508 bp element  
UPS ROP18 type III  CAGCTAAACTGCCCGCCCTCTTTCATT----CCTCTGTTT  
UPS ROP18 type I    ...........................AAGT..CG.....  
UPS ROP18 type II   ...........................AAGT..CG.....  
K119/2 2-C10        --------------------.......AAGT..CG.....  
K119/2 G11-C4       ------------------.........AAGT..CG.....  
B136/5_G12          --------...................AAGT..CG.....  
B136/1 B6-H6        --------...................AAGT..CG.....  
B136/1 A3-F5        ----------------------.....AAGT..CG.....  
K119/1 2-H8         ----------------------------------------  
K119/2 A7           ----------------------------------------  
B136/2 C12          ----------------------------------------  
 
                             50        60        70        80 
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  CAACGACGTCCATGAGTGCCTTTTTCTTTTCGTTTCCCGA  
UPS ROP18 type I    G..........GG...........................  
UPS ROP18 type II   G..........GG...........................  
K119/2 2-C10        G..........GG...........................  
K119/2 G11-C4       G..........GG...........................  
B136/5_G12          G..........GG...........................  
B136/1 B6-H6        G..........GG...........................  
B136/1 A3-F5        G..........GG...........................  
K119/1 2-H8         ----------------------------------------  
K119/2 A7           ----------------------------------------  
B136/2 C12          ----------------------------------------  
 
                             90       100       110       120 
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  CGCAGCAGCGAACCTAGCTGAATCTTCCAGCTTCGCTTTG  
UPS ROP18 type I    .......................A......T.........  
UPS ROP18 type II   ..T....................A......T.........  
K119/2 2-C10        ..T....................A......T.........  
K119/2 G11-C4       ..T....................A......T.........  
B136/5_G12          ..T....................A......T.........  
B136/1 B6-H6        ..T....................A......T.........  
B136/1 A3-F5        ..T....................A......T.........  
K119/1 2-H8         ---------...............................  
K119/2 A7           ........................................  











                            130       140       150       160 
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  AGTTCATAACTCCTTTGTTCTCTCTCTTCCGCCCGTCGGT  
UPS ROP18 type I    ...............G.....................C..  
UPS ROP18 type II   ...............C.....................A..  
K119/2 2-C10        ...............C.....................A..  
K119/2 G11-C4       ...............C.....................A..  
B136/5_G12          ...............C.....................A..  
B136/1 B6-H6        ...............C.....................A..  
B136/1 A3-F5        ...............C.....................A..  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          -------------------.....................  
 
                            170       180       190       200 
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  TCCCGTCCCTGGTGTCTTCGTGGCATTTTATTCAGTTCTA  
UPS ROP18 type I    ....T.................A.........A.......  
UPS ROP18 type II   ....T.................A.........A.......  
K119/2 2-C10        ....T.................A.........A.......  
K119/2 G11-C4       ....T.................A.........A.......  
B136/5_G12          ....T.................A.........A.......  
B136/1 B6-H6        ....T.................A.........A.......  
B136/1 A3-F5        ....T.................A.........A.......  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            210       220       230       240 
                    ....|....|....|....|....|....|....|....| 
Annotations                          1st 44 bp repeat element 
UPS ROP18 type III  TCGCGCCACTCGGACTTTGTTCCTGGCACCCTTTTGTAGC  
UPS ROP18 type I    ........................................  
UPS ROP18 type II   ........................................  
K119/2 2-C10        ........................................  
K119/2 G11-C4       ........................................  
B136/5_G12          ........................................  
B136/1 B6-H6        ........................................  
B136/1 A3-F5        ........................................  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ......A.................................  
  
                            250       260       270       280 
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  TAGGACTCCTTGACGAGTCAGTCAGATTGACGAGGTCGGC  
UPS ROP18 type I    ........................C...............  
UPS ROP18 type II   ........................................  
K119/2 2-C10        ........................................  
K119/2 G11-C4       ........................................  
B136/5_G12          ........................................  
B136/1 B6-H6        ........................................  
B136/1 A3-F5        ........................................  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  





                            290       300       310       320 
                    ....|....|....|....|....|....|....|....| 
Annotations           2nd 44 bp repeat element  
UPS ROP18 type III  TA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type I    ..~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ..GCTAGGACTCCTTGACGCGTCAGTCAGATTGACGAGGC  
K119/2 2-C10        ..GCTAGGACTCCTTGACGCGTCAGTCAGATTGACGAGGC  
K119/2 G11-C4       ..GCTAGGACTCCTTGACGCGTCAGTCAGATTGACGAGGC  
B136/5_G12          ..GCTAGGACTCCTTGACGCGTCAGTCAGATTGACGAGGC  
B136/1 B6-H6        ..GCTAGGACTCCTTGACGCGTCAGTCAGATTGACGAGGC  
B136/1 A3-F5        ..GCTAGGACTCCTTGACGCGTCAGTCAGATTGACGAGGC  
K119/1 2-H8         ..~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 A7           ..~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/2 C12          ..~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
 
                            330       340       350       360    
                    ....|....|....|....|....|....|....|....| 
Annotations               3rd 44 bp repeat element 
UPS ROP18 type III  ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   CGGCTAGCTAGGACTCCTTGACGCGTCAGTCAGATTGACG  
K119/2 2-C10        CGGCTAGCTAGGACTCCTTGACGCGTCAGTCAGATTGACG  
K119/2 G11-C4       CGGCTAGCTAGGACTCCTTGACGCGTCAGTCAGATTGACG  
B136/5_G12          CGGCTAGCTAGGACTCCTTGACGCGTCAGTCAGATTGACG  
B136/1 B6-H6        CGGCTAGCTAGGACTCCTTGACGCGTCAGTCAGATTGACG  
B136/1 A3-F5        CGGCTAGCTAGGACTCCTTGACGCGTCAGTCAGATTGACG  
K119/1 2-H8         ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 A7           ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/2 C12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
 
                            370       380       390       400    
                    ....|....|....|....|....|....|....|....| 
Annotations                   UPS-ROP18 
UPS ROP18 type III  ~~~~~~~~~~TTTACGAGAGACTGAAGCGTTGCCAGAAGC  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   AGGCCGGCTA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        AGGCCGGCTA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       AGGCCGGCTA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          AGGCCGGCTA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        AGGCCGGCTA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        AGGCCGGCTA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ~~~~~~~~~~..............................  
K119/2 A7           ~~~~~~~~~~..............................  




























                            410       420       430       440    
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  GGGGAATTTTTGTTTCTTCCTTTCTTCCCCAGAAAATTCG  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            450       460       470       480    
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  AGAAGCGACTTGAGGTCGGACAAGGCAGTGGGCTGGGCAT  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
                            490       500       510       520    
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  GCAGTGAAAAGCACTGTTTTCGTCTGAAACCGTTGCTCGG  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
 
                            530       540       550       560    
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  GATGTTGCTCAATGGAGTCATGGCACCGCATTCCTTTTTG  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  






                            570       580       590       600    
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  AAATGTGCCTCATGCCTTCTGTCCGTGCGTATTTTGTCCC  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            610       620       630       640    
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  TGTACCTGAATACTTACGGGATGCACTGGTCAGTTTCAGG  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            650       660       670       680    
                    ....|....|....|....|....|....|....|....| 
Annotations                                   ROP18-2F 
UPS ROP18 type III  CAGGATGATTGGTGCCGCCAACGTGCATCTTCGGGTAACA  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ....................................T...  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
                            690       700       710       720    
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  AACGTGAAGCACGTGTCACTAAGAAGAGGTTCCACTGACC  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  





                            730       740       750       760    
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  CTTTATATCCTGTGGCCATCCCCTATGCATCAGTTATTCA  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            770       780       790       800    
                    ....|....|....|....|....|....|....|....| 
Annotations                         ROP18-1R 
UPS ROP18 type III  GGGTGTTTTGTCAGTCAGGTTAGCCGGAAGTTTCCATCTA  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            810       820       830       840    
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  AACAGACACACTAAAGCGCCTAGGGTACTGAGTATGACTC  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            850       860       870       880    
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  AAGAAGCACTTTTCTATCGTAGGTTCGGTCTCACTAGGAA  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  





                            890       900       910       920    
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  TTAGAACAGCATGTCAAGTTCTTTCCCTGTTGTTACGCAT  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            930       940       950       960    
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  TATCGATGTACGCTTTTTACGCACGCTGTGCACTCATGTA  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            970       980       990       1000   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  CAGCAACCACAAAGGAGTTGATTGTCGACGAAGACGTTAG  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
 
                            1010      1020      1030      1040   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  TTCAGAGAAATTGAACGAAAGAAAGTCACATAGAAACGTT  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  





                            1050      1060      1070      1080   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  TTTCGCTCAACGCAGCCAGCACGCTAGTGTCCTTCGGGGT  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            1090      1100      1110      1120   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  AGTCAGTAAACACAAAACTGACTGGTGTCAAACCGATACA  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            1130      1140      1150      1160   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  CATGATGCCATTTCTTACGGCTGGTCCAGAGTCTGCATTC  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            1170      1180      1190      1200   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  ACCTACGGATGAGTACAGTGGTACGAACAGTCAGGGAAAA  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  






                            1210      1220      1230      1240   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  AATTGAACGGGTAGTTTCAGTAAACCTGTGTTCGTAGTTT  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            1250      1260      1270      1280   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  CTTCACACACTGGAGACAACCTTCCTGACACGTCGCTCCT  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            1290      1300      1310      1320   
                    ....|....|....|....|....|....|....|....| 
Annotations                     ROP18-3F 
UPS ROP18 type III  GCTTGTACGCGGTTGTAGCTCCTCTGAATTCAGGATTTTG  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            1330      1340      1350      1360   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  TGGTAGTGTCACGCTATACCGCTTCTCGGCTCTAGCTGTC  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  





                            1370      1380      1390      1400   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  GAGTATCCTGGTGCTTCTTACTTGGCAGGCGAGACAGTGA  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            1410      1420      1430      1440   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  CCGCTCCTGGTATACCCACGGTGCCACTGCGCAAACAGAA  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ....................CCC.................  
 
                            1450      1460      1470      1480   
                    ....|....|....|....|....|....|....|....| 
Annotations                                      ROP18-2R 
UPS ROP18 type III  TGGAATTGTAGAAATACTGAACAACTTGAGAAGATGGCGA  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            1490      1500      1510      1520   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  GCGCCCGGCTGCCTGTGATAGACGGTTTCAGTGAACAAAA  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  





                            1530      1540      1550      1560   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  ATAAGAACTCACTTAACTGCAACAGCCATTGTTGGTATAT  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            1570      1580      1590      1600   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  CTGTGCATCAAGAATATTCGACCGGGCAACCATCCTGTAT  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            1610      1620      1630      1640   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  TGCGAATAGGCAAACGACCATTTAACGTTCAAGTCGTTGC  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            1650      1660      1670      1680   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  CTGCCTTCAGTCCACATGTATGGTGTAGAGACCGTCTTTC  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  






                            1690      1700      1710      1720   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  ACTTGATGGTTGCTTGCTACAGCGCACTTTCGTGTTCGAC  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            1730      1740      1750      1760   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  GCCATAGGCGGTACATCCATTACTCGTAAGGAAAGGGAAC  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          .......-................................  
 
                            1770      1780      1790      1800   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  TATCTATCACAGGCAGTTTGGTGAATTGCGGTCGGTCACG  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            1810      1820      1830      1840   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  CACAGATCCATTCCACAACCTAACTCTGGAGGTAAACGCT  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  






                            1850      1860      1870      1880   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  GACTACTCCACGTGTGGCACAAACAAGGTGTCTGGCCTTT  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            1890      1900      1910      1920   
                    ....|....|....|....|....|....|....|....| 
Annotations                                   ROP18-4F 
UPS ROP18 type III  GTTTGCAAATAGACAGAGATGTTACCGTCCTCCGTTTTTC  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            1930      1940      1950      1960   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  TCTTTTTTCGTGGCTCATCTAAATGCGAAGTGCCGGTGAA  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            1970      1980      1990      2000   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  GTGTGTGCAACGAGTAGGGCACGCAAATATACAGCTTCAA  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  





                            2010      2020      2030      2040   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  AATGCCTGCCACTACGCAGTTCCTGAAAACAGTGCGTCGC  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            2050      2060      2070      2080   
                    ....|....|....|....|....|....|....|....| 
Annotations                                   ROP18-3R 
UPS ROP18 type III  TTTCGGAACCCAAGACTGGCTTCAAAGATGCAGCCAACGA  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            2090      2100      2110      2120   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  GACAAGCGTGACCGCGCAGCTGGCCATCTGTACGTCTTCA  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
                            2130      2140      2150      2160   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  CTTCCTCTATCTATTTCTGTTGGAGATGCTCTTGAGATGC  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  





                            2170      2180      2190      2200   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  CTCCCGTTCTCCACTCAACTTTGCTGTCTGGTTGAGCACC  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            2210      2220      2230      2240   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  ACAGTTCACTGTGAGACGCTTCACGAAAAGTGTTCCCCTA  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            2250      2260      2270      2280   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  GTCGACGCTTGGCACCGTTCGAGATAAATTAAACTGTCGG  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
  
                            2290      2300      2310      2320   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  CATTTGCGAATATGGCAAGGAATATGGAAAATAGTTTTTA  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  






                            2330      2340      2350      2360   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  ACACGGATACATAGGAAGACATACAGTTAATCTTTTTATC  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            2370      2380      2390      2400   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  GACATCCCGCTTCTTCTAGCAGACGGAGAGTCAGGCCTTT  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            2410      2420      2430      2440   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  AAGCTGTTGTTCACAAATTTCGAGCGCCAGTCACCAGAAC  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            2450      2460      2470      2480   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  GACCCGGTTTCCAGTGGCACCAGCAAGGCCTCCCTAAATC  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  






                            2490      2500      2510      2520   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  CGGAAGCAACTATAAGTAGTCGTAAGCAGCTCGAAGGGCA  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            2530      2540      2550      2560   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  ACACAGCATGAGCTTAAGAGTTGAAAAAGTCAGTGAAGTT  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
 
                            2570      2580      2590      2600   
                    ....|....|....|....|....|....|....|....| 
                                                99 bp element 
UPS ROP18 type III  CTTTTGGTAGAGAAAGCCATGAAGCGCTGAAGG~~~~~~~  
UPS ROP18 type I    ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GCCACGC  
UPS ROP18 type II   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GCCACGC  
K119/2 2-C10        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GCCACGC  
K119/2 G11-C4       ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GCCACGC  
B136/5_G12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GCCACGC  
B136/1 B6-H6        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GCCACGC  
B136/1 A3-F5        ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GCCACGC  
K119/1 2-H8         .................................~~~~~~~  
K119/2 A7           .................................~~~~~~~  
B136/2 C12          .................................~~~~~~~  
                            2610      2620      2630      2640   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type I    TATGCACCTCTTGCATACAATTGTTGTAGACAGCATGGTG  
UPS ROP18 type II   TATGCACCTCTTGCATACAATTGTTGTAGACAGCATGGTG  
K119/2 2-C10        TATGCACCTCTTGCATACAATTGTTGTAGACAGCATGGTG  
K119/2 G11-C4       TATGCACCTCTTGCATACAATTGTTGTAGACAGCATGGTG  
B136/5_G12          TATGCACCTCTTGCATACAATTGTTGTAGACAGCATGGTG  
B136/1 B6-H6        TATGCACCTCTTGCATACAATTGTTGTAGACAGCATGGTG  
B136/1 A3-F5        TATGCACCTCTTGCATACAATTGTTGTAGACAGCATGGTG  
K119/1 2-H8         ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 A7           ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  





                            2650      2660      2670      2680   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
UPS ROP18 type I    GTGTGCGAGACACTGCAGTCAAATGGCTCACCCAACGCCG  
UPS ROP18 type II   GTGTGCGAGACACTGCAGTCAAATGCCTCACCCAACGCCG  
K119/2 2-C10        GTGTGCGAGACACTGCAGTCAAATGCCTCACCCAACGCCG  
K119/2 G11-C4       GTGTGCGAGACACTGCAGTCAAATGCCTCACCCAACGCCG  
B136/5_G12          GTGTGCGAGACACTGCAGTCAAATGCCTCACCCAACGCCG  
B136/1 B6-H6        GTGTGCGAGACACTGCAGTCAAATGCCTCACCCAACGCCG  
B136/1 A3-F5        GTGTGCGAGACACTGCAGTCAAATGCCTCACCCAACGCCG  
K119/1 2-H8         ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
K119/2 A7           ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
B136/2 C12          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  
 
                            2690      2700      2710      2720   
                    ....|....|....|....|....|....|....|....| 
                                 108 bp element 
UPS ROP18 type III  ~~~~~~~~~~~~~TCGGCTACTCACGCTATGCTCGGCAGA  
UPS ROP18 type I    CGTCTCATTCTTCCAA.AAC..GT.CG.G.CT...A....  
UPS ROP18 type II   CGTCTCATTCTTCCAAAAAC..GT.CG.G.CT...A....  
K119/2 2-C10        CGTCTCATTCTTCCAAAAAC..GT.CG.G.CT...A....  
K119/2 G11-C4       CGTCTCATTCTTCCAAAAAC..GT.CG.G.CT...A....  
B136/5_G12          CGTCTCATTCTTCCAAAAAC..GT.CG.G.CT...A....  
B136/1 B6-H6        CGTCTCATTCTTCCAAAAAC..GT.CG.G.CT...A....  
B136/1 A3-F5        CGTCTCATTCTTCCAAAAAC..GT.CG.G.CT...A....  
K119/1 2-H8         ~~~~~~~~~~~~~...........................  
K119/2 A7           ~~~~~~~~~~~~~...........................  
B136/2 C12          ~~~~~~~~~~~~~...........................  
 
                            2730      2740      2750      2760   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  TTGATACAGCCGTTGACAAAGCACTACCATATTTTACAGT  
UPS ROP18 type I    .......................A................  
UPS ROP18 type II   .......................A................  
K119/2 2-C10        .......................A................  
K119/2 G11-C4       .......................A................  
B136/5_G12          .......................A................  
B136/1 B6-H6        .......................A................  
B136/1 A3-F5        .......................A................  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  
B136/2 C12          ........................................  
                            2770      2780      2790      2800   
                    ....|....|....|....|....|....|....|....| 
UPS ROP18 type III  TTTGTACTCACCCGAGTACAGTTTGTGTGAATGTTGTAAT  
UPS ROP18 type I    .............C...C.............A.....G..  
UPS ROP18 type II   .............C...C.............A.....G..  
K119/2 2-C10        .............C...C.............A.....G..  
K119/2 G11-C4       .............C...C.............A.....G..  
B136/5_G12          .............C...C.............A.....G..  
B136/1 B6-H6        .............C...C.............A.....G..  
B136/1 A3-F5        .............C...C.............A.....G..  
K119/1 2-H8         ........................................  
K119/2 A7           ........................................  





                            2810      2820      2830      2840   
                    ....|....|....|....|....|....|....|....| 
                    ROP18 trascriptional start 
UPS ROP18 type III  GTTTTCGGTACAGCGGCCATCTCTTACGTGTACCGTCGTC  
UPS ROP18 type I    ...................C........C...........  
UPS ROP18 type II   ...................C........C...........  
K119/2 2-C10        ...................C........C...........  
K119/2 G11-C4       ...................C........C...........  
B136/5_G12          ...................C........C...........  
B136/1 B6-H6        ...................C........C...........  
B136/1 A3-F5        ...................C........C...........  
K119/1 2-H8         .........................---------------  
K119/2 A7           ........................................  
B136/2 C12          ..--------------------------------------  
 
                            2850      2860      2870      2880   
                    ....|....|....|....|....|....|....|....| 
                                                 ROP18-4R 
UPS ROP18 type III  CGAATGGGTTTAGCGACTCTTCTCCGGAAGACAGCCTGTC  
UPS ROP18 type I    .........................C..............  
UPS ROP18 type II   .........................C..............  
K119/2 2-C10        .........................C.........-----  
K119/2 G11-C4       .........................C..............  
B136/5_G12          .........................C..............  
B136/1 B6-H6        .........................C..............  
B136/1 A3-F5        .........................C..............  
K119/2 A7           ...........-----------------------------  
 
                            2890      
                    ....|....|....|.... 
UPS ROP18 type III  TTGCGGGGTTAACTGTAGC  
UPS ROP18 type I    ............A......  
UPS ROP18 type II   ......T.....A......  
K119/2 G11-C4       ......-------------  
B136/5_G12          ..-----------------  
B136/1 B6-H6        .------------------  
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